GB1451669A
(en)
*
|
1974-01-02 |
1976-10-06 |
Radiochemical Centre Ltd |
Protein staining
|
JPS5112922A
(en)
*
|
1974-07-19 |
1976-01-31 |
Eiken Chemical |
Kasuitaihorumonno sokuteihoho
|
FR2288312A1
(en)
*
|
1974-10-14 |
1976-05-14 |
Pasteur Institut |
PROGESTERONE IMMUNOENZYMATIC ASSAY PROCESS
|
NL7501215A
(en)
*
|
1975-02-01 |
1976-08-03 |
Akzo Nv |
METHOD FOR DETERMINING AND DETERMINING AN ANTIGEN OR ANTIBODY.
|
USRE32696E
(en)
*
|
1975-09-04 |
1988-06-14 |
Akzona Incorporated |
Enzymatic immunological method for determination of antigens and antibodies
|
JPS52108017A
(en)
*
|
1976-03-04 |
1977-09-10 |
Eiken Chemical |
Measurement for thyroid gland hormon
|
JPS5341420A
(en)
*
|
1976-09-29 |
1978-04-14 |
Mochida Pharm Co Ltd |
Immunochemically measuring methoa of hapten
|
JPS5386013A
(en)
*
|
1976-11-24 |
1978-07-29 |
Ajinomoto Co Inc |
Quantitative analysis of pituitary hormone
|
IT1153999B
(en)
*
|
1977-03-15 |
1987-01-21 |
Snam Progetti |
COMPOSITION SUITABLE FOR DETERMINING TRIIODOTHYRONIN AND DIAGNOSTIC METHOD USING THE SAME
|
US4197287A
(en)
*
|
1977-06-10 |
1980-04-08 |
Ventrex Laboratories Inc. |
Method and apparatus for performing in nitro clinical diagnostic tests using a solid phase assay system having special utility for use with automatic pipetting equipment
|
US4235960A
(en)
*
|
1977-07-29 |
1980-11-25 |
The Medical College Of Wisconsin, Inc. |
Competitive enzyme-linked immunoassay
|
CA1108516A
(en)
*
|
1977-11-21 |
1981-09-08 |
Stanley E. Charm |
Antibiotic detection method
|
US4231750A
(en)
*
|
1977-12-13 |
1980-11-04 |
Diagnostic Reagents, Inc. |
Methods for performing chemical assays using fluorescence and photon counting
|
FR2422956A1
(en)
*
|
1978-04-13 |
1979-11-09 |
Pasteur Institut |
METHOD OF DETECTION AND CHARACTERIZATION OF A NUCLEIC ACID OR OF A SEQUENCE OF THE SAME, AND ENZYMATIC REAGENT FOR THE IMPLEMENTATION OF THIS PROCESS
|
US5605800A
(en)
*
|
1978-04-13 |
1997-02-25 |
Institut Pasteur |
Method of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
|
US4376165A
(en)
*
|
1978-06-22 |
1983-03-08 |
Miles Laboratories, Inc. |
Method of preparing an enzyme-labeled ligand for use in specific binding assays and the labeled conjugate produced thereby
|
US4238565A
(en)
*
|
1978-06-22 |
1980-12-09 |
Miles Laboratories, Inc. |
Specific binding assay with a prosthetic group as a label component
|
FR2432713A1
(en)
*
|
1978-08-02 |
1980-02-29 |
Inst Nat Sante Rech Med |
APPLICATION OF D5,3-CETO STEROIDE ISOMERASE IN IMMUNOENZYMATIC ASSAYS
|
JPS5545546A
(en)
*
|
1978-09-25 |
1980-03-31 |
Kanemitsu Doukou Yousetsushiyo:Goushi |
Production of sheet metal pulley
|
JPS5561329A
(en)
*
|
1978-10-27 |
1980-05-09 |
Toupure Kk |
Bulge forming method
|
JPS5575822A
(en)
*
|
1978-12-05 |
1980-06-07 |
Niigataken |
Hydraulic bulging method for metallic container
|
NZ192377A
(en)
*
|
1978-12-29 |
1981-11-19 |
Nat Res Dev |
Monitoring pregnancy in milk-producing domestic animals
|
US4278653A
(en)
*
|
1979-02-01 |
1981-07-14 |
New England Nuclear Corporation |
Methods and kits for double antibody immunoassay providing a colored pellet for easy visualization
|
US4289748A
(en)
*
|
1979-05-31 |
1981-09-15 |
United States Of America |
Ultrasensitive enzymatic radioimmunoassay method
|
US4318982A
(en)
*
|
1979-06-04 |
1982-03-09 |
Miles Laboratories, Inc. |
FMN-Labeled specific binding assay
|
US4340668A
(en)
*
|
1979-06-04 |
1982-07-20 |
Miles Laboratories, Inc. |
Heme-labeled specific binding assay
|
US4318983A
(en)
*
|
1979-06-04 |
1982-03-09 |
Miles Laboratories, Inc. |
Fad-labeled specific binding assay monitored with apoglutathione reductase or apolipoamide dehydrogenase
|
JPS55162059A
(en)
*
|
1979-06-05 |
1980-12-17 |
Mochida Pharmaceut Co Ltd |
Measuring method for antigen, antibody or their complex and measurement reagent kit
|
FR2459479B1
(en)
*
|
1979-06-21 |
1983-07-08 |
Inst Nat Sante Rech Med |
PROCESS FOR SEPARATING A PROTEIN SUBSTANCE FROM A SOLUTION CONTAINING IT BY AFFINITY FILTRATION AND APPLICATION OF SAID METHOD FOR ENZYMATIC ASSAYS
|
JPS564324A
(en)
*
|
1979-06-22 |
1981-01-17 |
Toupure Kk |
Bulging method
|
US4378344A
(en)
*
|
1979-09-28 |
1983-03-29 |
Ventrex Laboratories, Inc. |
Method and apparatus for performing multiple, simultaneous in vitro diagnostic tests using a solid phase system
|
GB2059421A
(en)
*
|
1979-10-03 |
1981-04-23 |
Self C H |
Assay method and reagents therefor
|
US4446231A
(en)
*
|
1979-10-03 |
1984-05-01 |
Self Colin H |
Immunoassay using an amplified cyclic detection system
|
US4410634A
(en)
*
|
1979-10-26 |
1983-10-18 |
Dynasciences Corporation |
Method of passively adsorbing immuno-reactive haptens to solid phases
|
JPS56501583A
(en)
*
|
1979-11-19 |
1981-10-29 |
|
|
US4347312A
(en)
*
|
1980-03-20 |
1982-08-31 |
Research Triangle Institute |
Detection of antibiotics in milk
|
JPS5714748A
(en)
*
|
1980-07-01 |
1982-01-26 |
Dainippon Pharmaceut Co Ltd |
Kit for quantitative determination of valproic acid and its method for quantitative determination
|
US4323647A
(en)
*
|
1980-10-15 |
1982-04-06 |
University Of Miami |
Steric hindrance enzyme immunoassay
|
US4604365A
(en)
*
|
1981-06-02 |
1986-08-05 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
EP0079962B1
(en)
*
|
1981-06-02 |
1985-08-28 |
Electro-Nucleonics, Inc. |
Immunoprecipitation assay
|
US4350659A
(en)
*
|
1981-07-30 |
1982-09-21 |
Corning Glass Works |
Stabilization of sensitive biologically active intermediate metabolites such as folic acid derivatives
|
US4506009A
(en)
*
|
1982-03-30 |
1985-03-19 |
University Of California |
Heterogeneous immunoassay method
|
US4535057A
(en)
*
|
1982-07-26 |
1985-08-13 |
Amf Incorporated |
Immunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
|
US4861705A
(en)
*
|
1983-01-31 |
1989-08-29 |
Yeda Research And Development Company, Ltd. |
Method for removing components of biological fluids
|
US4778752A
(en)
*
|
1983-10-11 |
1988-10-18 |
Scripps Clinic And Research Foundation |
Receptors specific for hapten-modified self proteins
|
US4727022A
(en)
*
|
1984-03-14 |
1988-02-23 |
Syntex (U.S.A.) Inc. |
Methods for modulating ligand-receptor interactions and their application
|
DE3430905A1
(en)
*
|
1984-08-22 |
1986-02-27 |
Boehringer Mannheim Gmbh, 6800 Mannheim |
METHOD FOR DETERMINING AN IMMUNOLOGICALLY BINDABLE SUBSTANCE
|
GB8428201D0
(en)
*
|
1984-11-08 |
1984-12-19 |
Glaxo Group Ltd |
Biological preparations
|
US4760142A
(en)
*
|
1984-11-27 |
1988-07-26 |
Hoechst Celanese Corporation |
Divalent hapten derivatives
|
CH670709A5
(en)
*
|
1986-04-24 |
1989-06-30 |
Univ Moskovsk |
|
US4868132A
(en)
*
|
1987-02-03 |
1989-09-19 |
Abbott Laboratories |
Fluorescence polarization immunoassay for amphetamine/methamphetamine
|
US5614504A
(en)
*
|
1990-08-01 |
1997-03-25 |
The University Of South Florida |
Method of making inosine monophosphate derivatives and immunopotentiating uses thereof
|
JPH0833394B2
(en)
*
|
1990-10-03 |
1996-03-29 |
三洋化成工業株式会社 |
Method for producing enzyme-labeled hapten
|
US6777190B1
(en)
|
1991-04-10 |
2004-08-17 |
Biosite, Inc. |
Crosstalk inhibitors and their uses
|
DE69228682T2
(en)
*
|
1991-04-10 |
1999-07-01 |
Biosite Diagnostics Inc |
"CROSSTALK" OR CROSS-CALL INHIBITORS AND THEIR USE
|
US5464749A
(en)
|
1991-07-22 |
1995-11-07 |
Bayer Corporation |
Immunoassay of free substances in biological fluids
|
US5874423A
(en)
*
|
1992-09-10 |
1999-02-23 |
Yissum Research Development Co. Of The Hebrew University Of Jerusalem |
Digitalis-like compounds
|
US5484709A
(en)
*
|
1993-09-10 |
1996-01-16 |
Ensys, Inc. |
Immunoassay method for detecting an immunologically non-remarkable compound, its components and a kit for use in performing the same
|
AU2635295A
(en)
*
|
1994-06-13 |
1996-01-05 |
Henry Ford Health System |
A novel neuronal-neonatal gene: neuronatin
|
US6531277B2
(en)
|
1994-10-25 |
2003-03-11 |
The Curators Of The University Of Missouri |
Endometriosis-specific secretory protein
|
US5843673A
(en)
*
|
1994-10-25 |
1998-12-01 |
Curators Of The University Of Missouri |
Method of screening for endometriosis
|
US5777093A
(en)
*
|
1995-05-16 |
1998-07-07 |
Ramot-University Authority For Applied Research & Industrial Development Ltd. |
cDNAs associated with ataxia-telangiectasia
|
US5858661A
(en)
*
|
1995-05-16 |
1999-01-12 |
Ramot-University Authority For Applied Research And Industrial Development |
Ataxia-telangiectasia gene and its genomic organization
|
US5728807A
(en)
*
|
1995-05-16 |
1998-03-17 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Mutated proteins associated with ataxia-telangiectasia
|
US5840322A
(en)
*
|
1996-12-19 |
1998-11-24 |
Ramot-University Authority For Applied Research & Industrial Devel. Ltd. |
Anti-oral-microbial adhesion fraction derived from vaccinium
|
US7973156B2
(en)
*
|
1997-08-21 |
2011-07-05 |
Quark Pharmaceuticals Inc. |
Hypoxia-regulated genes
|
US20030104973A1
(en)
*
|
1997-08-21 |
2003-06-05 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
WO1999009046A1
(en)
*
|
1997-08-21 |
1999-02-25 |
Quark Biotech, Inc. |
Hypoxia-regulated genes
|
US6284496B1
(en)
|
1997-10-03 |
2001-09-04 |
University Of South Florida |
DNA vector for determining the presence of out-of-reading-frame mutations
|
MXPA00003705A
(en)
|
1997-10-17 |
2002-04-17 |
Univ South Florida |
Method to diagnose and monitor cellular immune deficiencies.
|
US20080206206A1
(en)
|
1998-05-07 |
2008-08-28 |
University Of South Florida |
Bone marrow-derived neuronal cells
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
AU4994899A
(en)
|
1998-07-13 |
2000-02-01 |
University Of South Florida |
Modulation of the phospholipase a2 pathway as a therapeutic
|
US6187563B1
(en)
|
1998-08-07 |
2001-02-13 |
Yale University |
βIV-spectrin-polypeptides and nucleic acids encoding same
|
IL142094A0
(en)
*
|
1998-09-29 |
2002-03-10 |
Gamida Cell Ltd |
Methods of controlling proliferation and differentiation of stem and progenitor cells
|
ES2338405T3
(en)
*
|
1999-02-04 |
2010-05-07 |
Pluristem Ltd. |
METHOD AND APPARATUS FOR MAINTENANCE AND EXPASION OF HEMOPOYTIC MOTHER CELLS AND / OR PROGENITOR CELLS.
|
US6440682B1
(en)
*
|
1999-05-28 |
2002-08-27 |
Detroit R&D Inc. |
Detection of hypertension using immunoreactive metabolic products
|
US6787318B1
(en)
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
US7534605B2
(en)
*
|
1999-06-08 |
2009-05-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
|
US6875582B1
(en)
|
1999-08-19 |
2005-04-05 |
Omniscience Pharmaceuticals, Inc. |
Methods and targets of antibiotic resistance
|
US7101839B1
(en)
|
1999-08-30 |
2006-09-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US7811981B2
(en)
|
1999-08-30 |
2010-10-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Methods of and compositions for inhibiting the proliferation of mammalian cells
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
IL149698A0
(en)
|
1999-11-19 |
2002-11-10 |
Yissum Res Dev Co |
Aspergillus niger beta-glucosidase gene, protein and uses thereof
|
US6544506B2
(en)
*
|
2000-01-05 |
2003-04-08 |
Yeda Research & Development Co. Ltd. |
Veto cells effective in preventing graft rejection and devoid of graft versus host potential
|
US7385106B2
(en)
*
|
2000-01-24 |
2008-06-10 |
Ramot At Tel Aviv University Ltd. |
Plants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
|
US20040191260A1
(en)
*
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
CA2404489A1
(en)
|
2000-03-27 |
2001-10-04 |
Technion Research And Development Foundation Ltd. |
Single chain class i major histo-compatibility complexes, constructs encoding same and methods of generating same
|
IL135884A
(en)
*
|
2000-04-30 |
2005-08-31 |
Yissum Res Dev Co |
Method for measuring non-transferrin bound iron
|
HUP0300810A2
(en)
|
2000-07-20 |
2003-08-28 |
M.G.V.S. Ltd. |
Artifical vascular grafts, and methods of producing and using same
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
US20030114410A1
(en)
*
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
DK2078531T3
(en)
|
2000-08-08 |
2012-09-10 |
Technion Res & Dev Foundation |
Pharmaceutical compositions and methods that can be used to modulate angiogenesis
|
EP1683874A3
(en)
|
2000-08-29 |
2006-10-11 |
YEDA RESEARCH AND DEVELOPMENT Co. LTD. |
Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
|
US20070281037A9
(en)
*
|
2000-09-28 |
2007-12-06 |
Nanocyte Inc. |
Sterile preparations and compositions including stinging capsules and methods of producing and using same
|
EP1379127B1
(en)
|
2000-09-28 |
2013-04-17 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
|
US7632522B2
(en)
*
|
2000-09-28 |
2009-12-15 |
Nanocyte Inc. |
Use of stinging cells/capsules for the delivery of active agents to keratinous substances
|
WO2002040629A2
(en)
|
2000-11-17 |
2002-05-23 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same
|
US8071740B2
(en)
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
EP1341543A4
(en)
|
2000-11-24 |
2009-09-02 |
Vascular Biogenics Ltd |
Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
|
IL155941A0
(en)
*
|
2000-11-30 |
2003-12-23 |
Yeda Res & Dev |
Methods of utilizing cultured non-gvhd inducing t lymphocytes to treat disease
|
KR20030067696A
(en)
|
2000-11-30 |
2003-08-14 |
모렉큐랄 스킨케어 리미티드 |
Diagnosis and treatment of disease
|
US7087395B1
(en)
|
2001-01-16 |
2006-08-08 |
Quest Diagnostics Investments Incorporated |
Vitamin D assay
|
WO2002057408A2
(en)
*
|
2001-01-17 |
2002-07-25 |
Ramot At Tel Aviv University Ltd. |
Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
|
US20050202098A1
(en)
*
|
2001-01-31 |
2005-09-15 |
Tolaren |
Disease therapy using dying or dead cells
|
CA2475021A1
(en)
*
|
2001-01-31 |
2002-08-08 |
Dror Mevorach |
Induction of tolerance by apoptotic and/or necrotic cells
|
US20030003454A1
(en)
|
2001-03-23 |
2003-01-02 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Methods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
IL159944A0
(en)
*
|
2001-07-19 |
2004-06-20 |
Yissum Res Dev Co |
Polypeptides having carotenoid isomerase catalytic activity, nucleic acids encoding same and uses thereof
|
WO2003017817A2
(en)
|
2001-08-16 |
2003-03-06 |
Bar Ilan University |
Diagnosis, prevention and treatment of cancer
|
US7138144B2
(en)
*
|
2001-09-07 |
2006-11-21 |
Nadir Askenasy |
Method of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
|
US20040136972A1
(en)
|
2001-09-07 |
2004-07-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
|
CA2463816C
(en)
|
2001-10-19 |
2014-07-08 |
Vascular Biogenics Ltd. |
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
|
WO2003048298A2
(en)
*
|
2001-12-05 |
2003-06-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nanoparticles containing polymeric nucleic acid homologs, pharmaceutical compositions and articles of manufacture containing same and methods of use thereof
|
US20050085432A1
(en)
*
|
2001-12-26 |
2005-04-21 |
Aviva Lapidot |
Methods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
|
IL152904A0
(en)
*
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
WO2003062404A1
(en)
*
|
2002-01-25 |
2003-07-31 |
Gamida-Cell Ltd. |
Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
WO2003070752A2
(en)
*
|
2002-02-20 |
2003-08-28 |
Dyax Corporation |
Mhc-peptide complex binding ligands
|
EP1485464A4
(en)
*
|
2002-03-18 |
2006-11-29 |
Gamida Cell Ltd |
Methods of inducing differentiation in ex vivo expanded stem cells
|
IL164191A0
(en)
*
|
2002-03-26 |
2005-12-18 |
Nanocyte Inc |
Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosme tic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue nanocyte inc.
|
US20040121442A1
(en)
*
|
2002-05-05 |
2004-06-24 |
Ilan Chet |
Fungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
|
AU2003247143B2
(en)
|
2002-08-01 |
2009-07-16 |
Yeda Research And Development Co. Ltd. |
Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
|
US7267981B2
(en)
|
2002-10-07 |
2007-09-11 |
Technion Research & Development Foundation Ltd. |
Human foreskin fibroblasts for culturing ES cells
|
US20040146949A1
(en)
*
|
2002-10-25 |
2004-07-29 |
Jun Tan |
Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease
|
CA2504512A1
(en)
|
2002-10-30 |
2004-05-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Molecules and methods using same for measuring non-transferrin bound iron
|
US20050054097A1
(en)
*
|
2002-11-17 |
2005-03-10 |
Tony Peled |
EX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
|
AU2003302701A1
(en)
*
|
2002-11-29 |
2004-06-23 |
Technion Research And Development Foundation Ltd. |
Method of dynamically culturing embryonic stem cells
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
DK2338896T3
(en)
|
2002-12-12 |
2015-05-26 |
R B T Rakuto Bio Technologies Ltd |
USE OF lignin TO SKIN AND HÅRBLEGNING
|
WO2004055155A2
(en)
|
2002-12-16 |
2004-07-01 |
Technion Research & Development Foundation Ltd. |
Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same
|
ATE546548T1
(en)
|
2003-01-02 |
2012-03-15 |
Rappaport Family Inst For Res |
METHOD FOR PREDICTING THE BENEFIT OF ANTI-OXIDATION THERAPY FOR PREVENTING CARDIOVASCULAR DISEASE IN HYPERGLYCEMIC PATIENTS
|
ATE426575T1
(en)
*
|
2003-01-07 |
2009-04-15 |
Univ Ramot |
PEPTIDE ANOSTRUCTURES CONTAINING FOREIGN MATERIAL AND METHOD FOR PRODUCING THE SAME
|
US7786071B2
(en)
|
2003-03-04 |
2010-08-31 |
Yeda Research And Development Co. Ltd. |
Pon polypeptides polynucleotides encoding same and compositions and methods utilizing same
|
US8017113B2
(en)
|
2003-03-12 |
2011-09-13 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions and methods for diagnosing and treating an inflammation
|
ES2433440T3
(en)
|
2003-04-04 |
2013-12-11 |
Yeda Research And Development Co. Ltd. |
Antibodies against MMP2 or MMP9 and pharmaceutical compositions containing the same useful for inhibiting the activity of said metalloproteins
|
AU2004227204B2
(en)
|
2003-04-08 |
2010-06-03 |
Yeda Research And Development Co. Ltd |
Stem cells having increased sensitivity to SDF-1 and methods of generating and using same
|
FR2853551B1
(en)
|
2003-04-09 |
2006-08-04 |
Lab Francais Du Fractionnement |
STABILIZING FORMULATION FOR IMMUNOGLOBULIN G COMPOSITIONS IN LIQUID FORM AND LYOPHILIZED FORM
|
US7321065B2
(en)
*
|
2003-04-18 |
2008-01-22 |
The Regents Of The University Of California |
Thyronamine derivatives and analogs and methods of use thereof
|
US7554007B2
(en)
*
|
2003-05-22 |
2009-06-30 |
Evogene Ltd. |
Methods of increasing abiotic stress tolerance and/or biomass in plants
|
BRPI0411182B1
(en)
|
2003-05-22 |
2019-08-20 |
Evogene Ltd. |
METHOD FOR INCREASING TOLERANCE OF A SALT STRESS PLANT AND NUCLEIC ACID CONSTRUCTION
|
AU2005234725B2
(en)
|
2003-05-22 |
2012-02-23 |
Evogene Ltd. |
Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
|
US8129514B2
(en)
*
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
EP1636333A4
(en)
*
|
2003-06-19 |
2007-10-24 |
Evogene Ltd |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
EP1638517A4
(en)
*
|
2003-06-30 |
2010-01-06 |
Univ Tel Aviv Future Tech Dev |
Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases
|
JP2007518394A
(en)
*
|
2003-08-14 |
2007-07-12 |
ザ バイオ バランス コーポレイション |
Bacterial strain, composition containing the bacterial strain, and use of probiotics thereof
|
WO2005031362A2
(en)
|
2003-10-02 |
2005-04-07 |
Ramot At Tel Aviv University Ltd. |
Novel antibacterial agents and methods of identifying and utilizing same
|
IL158287A0
(en)
|
2003-10-07 |
2004-05-12 |
Yeda Res & Dev |
Antibodies to nik, their preparation and use
|
JP4943848B2
(en)
|
2003-10-07 |
2012-05-30 |
イエダ リサーチ アンド ディベロップメント カンパニー リミテッド |
Antibodies against NIK, their preparation and use
|
CN1918281A
(en)
*
|
2003-10-23 |
2007-02-21 |
辉瑞产品公司 |
Vaccine for periodontal disease
|
US8034340B2
(en)
|
2003-11-30 |
2011-10-11 |
Yeda Research And Development Ltd. |
Method for treating an immune disorder by decreasing NIK-SIVA complex formation
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
US20100221233A1
(en)
*
|
2003-12-15 |
2010-09-02 |
University Of South Florida |
Compositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
|
EP1722834B1
(en)
|
2003-12-22 |
2012-06-27 |
Regentis Biomaterials Ltd. |
Matrix comprising naturally-occurring crosslinked protein backbone
|
US8007847B2
(en)
*
|
2004-01-13 |
2011-08-30 |
Eytan Biderman |
Feeding formula appliance
|
US7423139B2
(en)
*
|
2004-01-20 |
2008-09-09 |
Insight Biopharmaceuticals Ltd. |
High level expression of recombinant human erythropoietin having a modified 5′-UTR
|
EP2816351A3
(en)
*
|
2004-01-27 |
2015-03-25 |
Compugen Ltd. |
Methods and systems for annotating biomolecular sequences
|
CA2558478A1
(en)
|
2004-03-02 |
2005-09-15 |
Acceleron Pharma Inc. |
Alk7 and myostatin inhibitors and uses thereof
|
US8352031B2
(en)
|
2004-03-10 |
2013-01-08 |
Impulse Dynamics Nv |
Protein activity modification
|
ES2665463T3
(en)
*
|
2004-06-14 |
2018-04-25 |
Evogene Ltd. |
Polynucleotides and polypeptides involved in the development of plant fiber and methods of use thereof
|
US8680062B2
(en)
*
|
2004-07-06 |
2014-03-25 |
Deliversir Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
WO2006006172A2
(en)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
WO2006030442A2
(en)
*
|
2004-09-16 |
2006-03-23 |
Gamida-Cell Ltd. |
Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
|
BRPI0516302A
(en)
*
|
2004-09-29 |
2008-09-02 |
Yissun Res Dev Company Of The |
recombinant human t2 rnase and its uses
|
EP2360261A1
(en)
|
2004-09-29 |
2011-08-24 |
CollPlant Ltd. |
Collagen producing plants and methods of generating and using same
|
US7781402B2
(en)
*
|
2004-10-12 |
2010-08-24 |
Closed Loop Therapies Ltd. |
Methods and implantable devices for treating supraventricular arrhythmias
|
US20060134680A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Alexander Kotlyar |
Homogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
|
EP1872604A4
(en)
*
|
2005-01-16 |
2010-01-20 |
Zlango Ltd |
Communications network system and methods for using same
|
WO2006075334A2
(en)
*
|
2005-01-16 |
2006-07-20 |
Zlango Ltd. |
Iconic communication
|
WO2007080558A2
(en)
*
|
2006-01-16 |
2007-07-19 |
Zlango Ltd. |
Communications network system and methods for using same
|
EP3028765B1
(en)
|
2005-01-31 |
2020-01-08 |
Realbio Technologies Ltd. |
Method of sequentially transferring liquids through a lateral flow capillary device
|
CA2597699C
(en)
|
2005-02-17 |
2012-07-31 |
Hadasit Medical Research Services And Development Ltd. |
Bisphosphonates for treating endometriosis
|
US8216801B2
(en)
|
2005-02-25 |
2012-07-10 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), The Volcani Center |
Methods for treating inflammatory disorders
|
US7695927B2
(en)
*
|
2005-03-18 |
2010-04-13 |
Detroit R & D |
Detection of hypertension using glucuronidated metabolic products
|
EP1874334A4
(en)
*
|
2005-04-15 |
2011-03-30 |
Vascular Biogenics Ltd |
Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease
|
US8834862B2
(en)
*
|
2005-04-19 |
2014-09-16 |
Nanocyte Inc. |
Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
|
EP1888034A2
(en)
|
2005-05-26 |
2008-02-20 |
Yissum Research Development Company, of The Hebrew University of Jerusalem |
Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
|
ES2524996T3
(en)
|
2005-06-16 |
2014-12-16 |
Ramot At Tel Aviv University Ltd. |
Isolated cells and populations that comprise them for the treatment of CNS diseases
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
EP1904526A4
(en)
|
2005-07-07 |
2009-10-28 |
Fulcrum Sp Ltd |
Sp1 polypeptides, modified sp1 polypeptides and uses thereof
|
WO2007007317A1
(en)
|
2005-07-07 |
2007-01-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acid agents for downregulating h19, and methods of using same
|
CA2615218A1
(en)
|
2005-07-18 |
2007-01-25 |
Protalix Ltd. |
Mucosal or enteral administration of biologically active macromolecules
|
JP5017269B2
(en)
|
2005-07-26 |
2012-09-05 |
ユニヴァーシティ オブ メディシン アンド デンティストリ オブ ニュージャーシィ |
Antibody profile specific to tuberculosis
|
CA2615460A1
(en)
*
|
2005-08-08 |
2007-02-15 |
Onconon, Llc |
Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
|
EP1928479B1
(en)
|
2005-08-24 |
2016-06-08 |
Yeda Research And Development Co., Ltd. |
Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
|
AU2006286149B2
(en)
|
2005-08-29 |
2012-09-13 |
Technion Research And Development Foundation Ltd. |
Media for culturing stem cells
|
DE602006014009D1
(en)
*
|
2005-09-22 |
2010-06-10 |
Yissum Res Dev Co |
NUCLEIC ACID CONSTRUCTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
|
US20070087437A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jifan Hu |
Methods for rejuvenating cells in vitro and in vivo
|
EP2716654A1
(en)
|
2005-10-24 |
2014-04-09 |
Evogene Ltd. |
Isolated polypeptides, polynucleotides encoding same, transgenic plants expressing same and methods of using same
|
AU2006321172B2
(en)
|
2005-11-29 |
2012-02-23 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
WO2007080559A2
(en)
|
2006-01-16 |
2007-07-19 |
Zlango Ltd. |
Iconic communication
|
US10221228B2
(en)
|
2006-02-03 |
2019-03-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US10351615B2
(en)
|
2006-02-03 |
2019-07-16 |
Opko Biologics Ltd. |
Methods of treatment with long-acting growth hormone
|
US8048849B2
(en)
|
2006-02-03 |
2011-11-01 |
Modigene, Inc. |
Long-acting polypeptides and methods of producing same
|
US8450269B2
(en)
|
2006-02-03 |
2013-05-28 |
Prolor Biotech Ltd. |
Long-acting growth hormone and methods of producing same
|
US8476234B2
(en)
|
2006-02-03 |
2013-07-02 |
Prolor Biotech Inc. |
Long-acting coagulation factors and methods of producing same
|
US7553940B2
(en)
*
|
2006-02-03 |
2009-06-30 |
Modigene Inc |
Long-acting EPO polypeptides and derivatives thereof and methods thereof
|
US20140113860A1
(en)
|
2006-02-03 |
2014-04-24 |
Prolor Biotech Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US9249407B2
(en)
|
2006-02-03 |
2016-02-02 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US9458444B2
(en)
|
2006-02-03 |
2016-10-04 |
Opko Biologics Ltd. |
Long-acting coagulation factors and methods of producing same
|
US8759292B2
(en)
|
2006-02-03 |
2014-06-24 |
Prolor Biotech, Llc |
Long-acting coagulation factors and methods of producing same
|
US8946155B2
(en)
|
2006-02-03 |
2015-02-03 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
US8048848B2
(en)
|
2006-02-03 |
2011-11-01 |
Prolor Biotech Ltd. |
Long-acting interferons and derivatives thereof and methods thereof
|
US20150038413A1
(en)
|
2006-02-03 |
2015-02-05 |
Opko Biologics Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
EP1989554A1
(en)
|
2006-02-06 |
2008-11-12 |
Rappaport Family Institute For Research in the Medical Sciences |
Methods and kit for diagnosing t1dm
|
CA2641954C
(en)
|
2006-03-06 |
2016-04-26 |
Zetiq Technologies Ltd. |
Methods and compositions for identifying a cell phenotype
|
PT2366775E
(en)
|
2006-03-23 |
2015-07-20 |
Pluristem Ltd |
Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
|
WO2007110869A2
(en)
|
2006-03-28 |
2007-10-04 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to warfarin resistance
|
US8071323B2
(en)
*
|
2006-04-07 |
2011-12-06 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Human monoclonal antibodies that bind human insulin like growth factors and their use
|
AU2007254167B2
(en)
*
|
2006-05-19 |
2012-11-15 |
Technion Research And Development Foundation Ltd. |
Fusion proteins, uses thereof and processes for producing same
|
US20070281883A1
(en)
*
|
2006-06-05 |
2007-12-06 |
Hanna Rosenfeld |
Development of follicle stimulating hormone agonists and antagonists in fish
|
EP2046109A4
(en)
|
2006-07-20 |
2010-01-06 |
Yeda Res & Dev |
Photosyntheticorganisms and compositions and methods of generating same
|
EP2064319B1
(en)
|
2006-08-28 |
2017-02-22 |
Yeda Research and Development Co. Ltd. |
Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns
|
JP2010502729A
(en)
*
|
2006-09-08 |
2010-01-28 |
ウィスコンシン アルムニ リサーチ ファウンデーション |
Assay for antibodies against B. pneumoniae
|
US7888059B2
(en)
*
|
2006-10-05 |
2011-02-15 |
Yeda Research And Development Co. Ltd. |
Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
|
CN101595251B
(en)
|
2006-10-05 |
2014-06-11 |
技术研究及发展基金有限公司 |
Microtubes and methods of producing same
|
US20080131954A1
(en)
*
|
2006-11-30 |
2008-06-05 |
Canon U.S. Life Sciences, Inc. |
Method of Separating Target DNA from Mixed DNA
|
EP2096909A4
(en)
|
2006-12-20 |
2010-08-04 |
Evogene Ltd |
Polynucleotides and polypeptides involved in plant fiber development and methods of using same
|
US20100086526A1
(en)
*
|
2007-01-16 |
2010-04-08 |
Abraham Hochberg |
Nucleic acid constructs and methods for specific silencing of h19
|
US20100196403A1
(en)
*
|
2007-01-29 |
2010-08-05 |
Jacob Hochman |
Antibody conjugates for circumventing multi-drug resistance
|
US8911996B2
(en)
|
2007-01-31 |
2014-12-16 |
Technion Research & Development Foundation Limited |
Electrospun scaffolds and methods of generating and using same
|
WO2008093342A2
(en)
|
2007-02-01 |
2008-08-07 |
Technion Research & Development Foundation Ltd. |
Albumin fibers and fabrics and methods of generating and using same
|
WO2008104979A2
(en)
|
2007-02-28 |
2008-09-04 |
Yeda Research And Development Co. Ltd. |
Nuclear targeting sequences
|
EP2514766A3
(en)
|
2007-03-29 |
2013-06-05 |
Technion Research & Development Foundation Ltd. |
Antibodies, methods and kits for diagnosing and treating melanoma
|
JP2010523104A
(en)
|
2007-04-02 |
2010-07-15 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド |
Cancer cell detection method and use thereof for diagnosis of cancer disease and monitoring of treatment of cancer disease
|
MX2009010858A
(en)
*
|
2007-04-09 |
2009-11-02 |
Evogene Ltd |
Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants.
|
ES2516827T3
(en)
*
|
2007-04-23 |
2014-10-31 |
Deliversir Ltd |
A system to deliver therapeutic agents to living cells and cell nuclei
|
US9156865B2
(en)
|
2007-04-23 |
2015-10-13 |
Deliversir Ltd |
System for delivering therapeutic agents into living cells and cells nuclei
|
US9556210B2
(en)
|
2007-04-23 |
2017-01-31 |
Sabag-Rfa Ltd. |
System for delivering therapeutic agents into living cells and cells nuclei
|
ES2564312T3
(en)
|
2007-05-01 |
2016-03-21 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits to detect fetal cells in maternal blood
|
ES2846400T3
(en)
|
2007-05-03 |
2021-07-28 |
Agency For Science Tech And Research Astarstar |
Antibodies that bind to an intracellular PRL-1 or PRL-3 polypeptide
|
ES2660667T3
(en)
|
2007-05-07 |
2018-03-23 |
Protalix Ltd. |
Large-scale disposable bioreactor
|
EP2176409B1
(en)
|
2007-07-11 |
2012-01-04 |
Yeda Research And Development Co. Ltd. |
Nucleic acid construct systems capable of diagnosing or treating a cell state
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
CA2696833A1
(en)
|
2007-07-15 |
2009-01-22 |
Yitzchak Hillman |
Disease treatment via antimicrobial peptides or their inhibitors
|
ES2547305T3
(en)
|
2007-07-24 |
2015-10-05 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded by them, and methods of using them to increase tolerance to abiotic stress and / or biomass and / or yield in plants that express them
|
US8461303B2
(en)
*
|
2007-08-02 |
2013-06-11 |
Gilead Biologics, Inc. |
LOX and LOXL2 inhibitors and uses thereof
|
ES2406105T3
(en)
|
2007-08-15 |
2013-06-05 |
Yeda Research And Development Co. Ltd. |
MMP-9 regulators and their uses
|
EP2195650B1
(en)
|
2007-09-12 |
2016-07-06 |
Yeda Research And Development Company Ltd. |
Methods of treating tumors in immune-privileged sites
|
PL2200622T5
(en)
|
2007-09-19 |
2016-08-31 |
Pluristem Ltd |
Adherent cells from adipose or placenta tissues and use thereof in therapy
|
AU2008313274A1
(en)
|
2007-10-19 |
2009-04-23 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
|
JP2011504374A
(en)
|
2007-11-26 |
2011-02-10 |
イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド |
Composition comprising fibrous polypeptide and polysaccharide
|
CA2709517C
(en)
|
2007-12-27 |
2019-02-26 |
Evogene Ltd. |
Isolated polypeptides, polynucleotides useful for modifying water use efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
|
CA2713667A1
(en)
*
|
2008-01-31 |
2009-08-06 |
Compugen Ltd. |
Cd55 isoform and uses therof in cancer detection, monitoring and therapy
|
WO2009104174A2
(en)
|
2008-02-21 |
2009-08-27 |
Technion Research & Development Foundation Ltd . |
A method of attaching a cell-of-interest to a microtube
|
US8153383B2
(en)
*
|
2008-03-18 |
2012-04-10 |
Wisconsin Alumni Research Foundation |
Mycobacterial culture screening test for Mycobacterium avium complex bacteria
|
WO2009125394A1
(en)
*
|
2008-04-09 |
2009-10-15 |
Technion Research & Development Foundation Ltd. |
Anti human immunodeficiency antibodies and uses thereof
|
WO2009125381A1
(en)
*
|
2008-04-10 |
2009-10-15 |
Objet Geometries Ltd. |
System and method for three dimensional model printing
|
US9095569B2
(en)
|
2008-04-18 |
2015-08-04 |
Collplant Ltd. |
Methods of generating and using procollagen
|
MX2010011511A
(en)
|
2008-04-21 |
2011-06-09 |
Danziger Innovations Ltd |
Plant viral expression vectors and use of same for generating genotypic variations in plant genomes.
|
SG157299A1
(en)
|
2008-05-09 |
2009-12-29 |
Agency Science Tech & Res |
Diagnosis and treatment of kawasaki disease
|
TR201808744T4
(en)
*
|
2008-05-22 |
2018-07-23 |
Evogene Ltd |
Isolated polynucleotides and polypeptides and methods for their use to enhance plant benefit.
|
US9393273B2
(en)
|
2008-05-27 |
2016-07-19 |
Pluristem Ltd. |
Methods of treating inflammatory colon diseases
|
ES2729557T3
(en)
|
2008-05-28 |
2019-11-04 |
Univ Ramot |
Mesenchymal stem cells for the treatment of CNS diseases
|
CN102076415B
(en)
|
2008-06-29 |
2015-06-24 |
瑞尔比奥技术有限公司 |
Liquid-transfer device particularly useful as a capturing device in a biological assay process
|
EP2320953B1
(en)
|
2008-08-08 |
2015-07-15 |
Genisphere, LLC |
Long-acting dna dendrimers and methods thereof
|
GB2474807A
(en)
|
2008-08-08 |
2011-04-27 |
Agency Science Tech & Res |
Vhz for diagnosis and treatment of cancers
|
BR122021014193B1
(en)
*
|
2008-08-18 |
2022-08-30 |
Evogene Ltd |
METHOD TO INCREASE NITROGEN USE EFFICIENCY, FERTILIZER USE EFFICIENCY, PRODUCTION, GROWTH RATE, VIGOR, BIOMASS AND/OR STRESS TOLERANCE DUE TO A PLANT NUTRIENT DEFICIENCY
|
SG190659A1
(en)
|
2008-09-02 |
2013-06-28 |
Pluristem Ltd |
Adherent cells from placenta tissue and use thereof in therapy
|
US8367392B2
(en)
*
|
2008-09-05 |
2013-02-05 |
Transalgae Ltd. |
Genetic transformation of algal and cyanobacteria cells by microporation
|
US20110305682A1
(en)
|
2008-09-11 |
2011-12-15 |
Ben Gurion University Of The Negev Research And Development Authority |
Compositions and Methods for Treating S. Pneumonia Infection
|
JP6105846B2
(en)
|
2008-09-12 |
2017-03-29 |
クライオプラキス クライオバイオロヒア エリテーデーアー. |
Cell therapy of ischemic tissue
|
KR101594202B1
(en)
|
2008-09-24 |
2016-02-15 |
텔 하쇼머 메디컬 리서치 인프라스트럭쳐 앤드 서비시스 리미티드. |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
WO2010035261A2
(en)
|
2008-09-29 |
2010-04-01 |
Ben Gurion University Of The Negev Research And Development Authority |
Amyloid beta-peptides and methods of use thereof
|
WO2010049897A2
(en)
|
2008-10-30 |
2010-05-06 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficieny
|
US20110229892A1
(en)
|
2008-11-17 |
2011-09-22 |
Yehuda G Assaraf |
Method for predicting a patient's responsiveness to anti-folate therapy
|
WO2010058396A1
(en)
|
2008-11-19 |
2010-05-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
A cd44vra antibody and diagnostic and therapeutic methods using same
|
WO2010061383A1
(en)
|
2008-11-26 |
2010-06-03 |
Biodalia Microbiological Technologies Ltd. |
A method of in-situ enrichment of foods with fructan
|
WO2010064231A1
(en)
|
2008-12-02 |
2010-06-10 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
|
US20120014927A1
(en)
|
2008-12-03 |
2012-01-19 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Methods and kits for determining predisposition to cancer
|
EP2633854B1
(en)
|
2008-12-05 |
2015-09-16 |
Yeda Research And Development Co. Ltd. |
miRNA-9 or miRNA-9* for use in treating ALS
|
WO2010071610A1
(en)
|
2008-12-19 |
2010-06-24 |
Agency For Science, Technology And Research (A*Star) |
Severe chikungunya biomarkers
|
WO2010076788A2
(en)
|
2008-12-29 |
2010-07-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection
|
SG10201504379VA
(en)
|
2008-12-29 |
2015-07-30 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
Peptides and compositions for prevention of cell adhesion and methods of using same
|
WO2010076756A2
(en)
|
2008-12-29 |
2010-07-08 |
Evogene Ltd. |
Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same
|
WO2010076794A1
(en)
|
2008-12-31 |
2010-07-08 |
Technion Research & Development Foundation Ltd. |
Method of denitrifying brine and systems capable of same
|
WO2010080769A2
(en)
*
|
2009-01-06 |
2010-07-15 |
Arresto Biosciences, Inc. |
Chemotherapeutic methods and compositions
|
IL196820A0
(en)
|
2009-02-01 |
2009-11-18 |
Yissum Res Dev Co |
Devitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
|
EP2391377A2
(en)
|
2009-02-02 |
2011-12-07 |
Ramot at Tel-Aviv University Ltd. |
Peptides, pharmaceutical compositions comprising same and uses thereof
|
WO2010089707A1
(en)
|
2009-02-04 |
2010-08-12 |
Yeda Research And Development Co. Ltd. |
Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
|
WO2010097793A2
(en)
|
2009-02-26 |
2010-09-02 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Isolated populations of renal stem cells and methods of isolating and using same
|
EP3460062B1
(en)
|
2009-03-02 |
2021-05-05 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
|
ES2564265T3
(en)
|
2009-03-09 |
2016-03-21 |
Ramot At Tel-Aviv University Ltd. |
Compositions for prevention and treatment of neurodegenerative diseases
|
WO2010103517A1
(en)
|
2009-03-12 |
2010-09-16 |
Rappaport Family Institute For Research In The Medical Sciences |
Soluble compositions for the treatment of cxcr3-ligand associated diseases
|
US20120020954A1
(en)
|
2009-03-30 |
2012-01-26 |
Anat Achiron |
Methods of predicting clinical course and treating multiple sclerosis
|
CA2759201A1
(en)
|
2009-04-01 |
2010-10-07 |
The Medical Research, Infrastructure, And Health Services Fund Of The Te L Aviv Medical Center |
A method of regulating proliferation and differentiation of keratinocyes
|
WO2010116375A1
(en)
|
2009-04-08 |
2010-10-14 |
Yeda Research And Development Co. Ltd. |
Isolated peptides for regulating apoptosis
|
AU2010243211B2
(en)
|
2009-04-30 |
2014-01-30 |
Ramot At Tel Aviv University Ltd. |
Anti CEACAM1 antibodies and methods of using same
|
CN102576024B
(en)
|
2009-05-19 |
2016-10-26 |
泽蒂克科技有限公司 |
The test kit of the differential staining of cervical cancer cell and/or tissue and method
|
EP2435072A2
(en)
|
2009-05-27 |
2012-04-04 |
Yeda Research and Development Co. Ltd. |
Proteasome inhibitors and uses thereof
|
US20120078163A1
(en)
|
2009-05-27 |
2012-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of generating connective tissue
|
WO2010137013A1
(en)
|
2009-05-27 |
2010-12-02 |
Ramot At Tel Aviv University Ltd. |
Crystallized photosystem i units from the pea plant and their use in solid state devices
|
US20120070449A1
(en)
|
2009-05-28 |
2012-03-22 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
CA3095630A1
(en)
|
2009-06-10 |
2010-12-16 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
AU2010264072A1
(en)
|
2009-06-24 |
2012-02-16 |
Health Corporation - Rambam |
Methods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
|
US9663778B2
(en)
|
2009-07-09 |
2017-05-30 |
OPKO Biologies Ltd. |
Long-acting coagulation factors and methods of producing same
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
ES2753986T3
(en)
|
2009-07-21 |
2020-04-15 |
Tel Hashomer Medical Res Infrastructure & Services Ltd |
A method of diagnosing cancer
|
GB0913442D0
(en)
|
2009-07-31 |
2009-09-16 |
Univ Ramot |
Cell-targeting nanoparticles comprising polynucleotide agents and uses thereof
|
WO2011021194A2
(en)
|
2009-08-17 |
2011-02-24 |
Technion Research & Development Foundation Ltd. |
Pericyte progenitor cells and methods of generating and using same
|
BR112012008078A2
(en)
|
2009-08-21 |
2017-07-04 |
Beeologics Inc |
Prevention and cure of beneficial insect diseases through transcribed plant molecules.
|
WO2011022709A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Arresto Biosciences, Inc |
In vitro screening assays
|
AU2010284001A1
(en)
*
|
2009-08-21 |
2012-03-22 |
Gilead Biologics, Inc. |
Therapeutic methods and compositions
|
SG2014004816A
(en)
*
|
2009-08-21 |
2014-03-28 |
Gilead Biologics Inc |
Catalytic domains from lysyl oxidase and loxl2
|
WO2011022670A1
(en)
*
|
2009-08-21 |
2011-02-24 |
Arresto Biosciences, Inc |
In vivo screening assays
|
CN102711839A
(en)
*
|
2009-08-21 |
2012-10-03 |
吉联亚生物科技有限公司 |
In vivo screening assays
|
CN106619515A
(en)
|
2009-08-27 |
2017-05-10 |
工业研究与发展基金会有限公司 |
Liposomal compositions and uses of same
|
WO2011030332A2
(en)
|
2009-09-08 |
2011-03-17 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
WO2011030336A1
(en)
|
2009-09-08 |
2011-03-17 |
Ramot At Tel-Aviv University Ltd. |
Methods of diagnosing amyotrophic lateral sclerosis (als)
|
US20120171213A1
(en)
|
2009-09-10 |
2012-07-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating tumors
|
US8735124B2
(en)
|
2009-09-17 |
2014-05-27 |
Yeda Research And Development Co. Ltd. |
Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
EP2478009B1
(en)
|
2009-09-17 |
2016-06-01 |
Ramot at Tel-Aviv University Ltd. |
Peptides for the treatment of oxidative stress related disorders
|
WO2011033506A2
(en)
|
2009-09-17 |
2011-03-24 |
Yeda Research And Development Co. Ltd. |
Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
US20110081706A1
(en)
*
|
2009-10-02 |
2011-04-07 |
TransAlgae Ltd |
Method and system for efficient harvesting of microalgae and cyanobacteria
|
US8962584B2
(en)
|
2009-10-14 |
2015-02-24 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. |
Compositions for controlling Varroa mites in bees
|
CA2777448C
(en)
|
2009-10-14 |
2023-02-28 |
Ilan Sela |
Compositions for controlling varroa mites in bees
|
CA2777663A1
(en)
|
2009-10-16 |
2011-04-21 |
University Of Medicine And Dentistry Of New Jersey |
Method for treating chronic nerve tissue injury using a cell therapy strategy
|
WO2011048600A1
(en)
|
2009-10-21 |
2011-04-28 |
Danziger Innovations Ltd. |
Generating genotypic variations in plant genomes by gamete infection
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
Knock-out mouse of the mo-1 gene, a gene associated with morbid obesity
|
US8962561B2
(en)
|
2009-11-12 |
2015-02-24 |
Ramot At Tel-Aviv University Ltd. |
Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes
|
WO2011058555A1
(en)
|
2009-11-12 |
2011-05-19 |
Yeda Research And Development Co. Ltd. |
A method of editing dna in a cell and constructs capable of same
|
EP2499236B1
(en)
|
2009-11-12 |
2020-01-01 |
Technion Research & Development Foundation Ltd. |
Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
|
US20120230974A1
(en)
|
2009-11-17 |
2012-09-13 |
Protalix Ltd |
Alkaline alpha galactosidase for the treatment of fabry disease
|
WO2011064773A1
(en)
|
2009-11-24 |
2011-06-03 |
Collplant Ltd. |
Method of generating collagen fibers
|
NZ600651A
(en)
|
2009-11-30 |
2014-07-25 |
Pluristem Ltd |
Adherent cells from placenta and use of same in disease treatment
|
US9562235B2
(en)
|
2009-12-06 |
2017-02-07 |
A.B. Seeds Ltd. |
MicroRNA compositions and methods for enhancing plant resistance to abiotic stress
|
EP2510098B1
(en)
|
2009-12-09 |
2015-02-11 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the cns
|
CA2784342C
(en)
|
2009-12-28 |
2022-11-22 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
|
ES2851601T3
(en)
|
2009-12-29 |
2021-09-08 |
Gamida Cell Ltd |
Methods to enhance the proliferation and activity of natural killer cells
|
AU2011204405B2
(en)
|
2010-01-05 |
2015-06-18 |
Vascular Biogenics Ltd. |
Methods for use of a specific anti-angiogenic adenoviral agent
|
SG10201500015TA
(en)
|
2010-01-12 |
2015-02-27 |
Vascular Biogenics Ltd |
Methods of producing adenovirus vectors and viral preparations generated thereby
|
WO2011092700A1
(en)
|
2010-01-27 |
2011-08-04 |
Yeda Research And Development Co. Ltd. |
Antibodies that inhibit metalloproteins
|
RU2015108348A
(en)
|
2010-02-04 |
2015-07-20 |
Джилид Байолоджикс, Инк. |
ANTIBODIES BINDING WITH LYSYLOXIDASE-LIKE ENZYME-2 (LOXL2), AND WAYS OF THEIR APPLICATION
|
US9410131B2
(en)
|
2010-02-11 |
2016-08-09 |
Yeda Research And Development Co. Ltd. |
Enzymatic systems for carbon fixation and methods of generating same
|
US20130109615A1
(en)
|
2010-02-24 |
2013-05-02 |
Ben Gurion University Of The Negev Research And Development Authority |
Methods for inhibiting necrosis
|
WO2011107939A1
(en)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
|
WO2011107994A1
(en)
|
2010-03-04 |
2011-09-09 |
Yeda Research And Development Co. Ltd. |
Methods of measuring protein stability
|
EP2545176B1
(en)
|
2010-03-08 |
2016-05-11 |
Yeda Research and Development Co. Ltd. |
Recombinant protein production in heterologous systems
|
AU2011224570B2
(en)
|
2010-03-08 |
2014-08-14 |
Monsanto Technology Llc |
Polynucleotide molecules for gene regulation in plants
|
US20120329089A1
(en)
|
2010-03-11 |
2012-12-27 |
Jacob Edrei |
Methods of generating hydrogen
|
WO2011125015A2
(en)
|
2010-04-05 |
2011-10-13 |
Bar-Ilan University |
Protease-activatable pore-forming polypeptides
|
WO2011128897A1
(en)
|
2010-04-12 |
2011-10-20 |
Technion Research & Development Foundation Ltd. |
Populations of pancreatic progenitor cells and methods of isolating and using same
|
US9458438B2
(en)
|
2010-04-12 |
2016-10-04 |
Ben Gurion University Of The Negev Research And Development Authority |
Sulfotransferase of a red microalga and uses thereof
|
JP5858984B2
(en)
|
2010-04-18 |
2016-02-10 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
Molecules for treating diseases related to ErbB / ErbB ligands and methods of using the molecules
|
BR122021002353B1
(en)
|
2010-04-28 |
2022-08-16 |
Evogene Ltd |
METHOD OF INCREASE PRODUCTION, BIOMASS, GROWTH RATE, VIGOR, ABIOTIC STRESS TOLERANCE AND/OR NITROGEN USE EFFICIENCY OF A PLANT, AND, ISOLATED NUCLEIC ACID CONSTRUCTION
|
WO2011138778A2
(en)
|
2010-05-04 |
2011-11-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of identifying inhibitors of polypeptides-of-interest
|
EP2566500B1
(en)
|
2010-05-05 |
2017-04-12 |
Rappaport Family Institute for Research in the Medical Sciences |
Ccl1 for use in therapy
|
IL208820A0
(en)
|
2010-10-19 |
2011-01-31 |
Rachel Teitelbaum |
Biologic female contraceptives
|
PL2569417T3
(en)
|
2010-05-13 |
2018-12-31 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Isolated populations of adult renal cells and methods of isolating and using same
|
WO2011151833A1
(en)
|
2010-06-03 |
2011-12-08 |
Ramot At Tel-Aviv University Ltd. |
Methods of treating diabetes and compositions capable of same
|
MX2012014284A
(en)
|
2010-06-07 |
2013-04-29 |
Osnat Ashur-Fabian |
Methods and kits for diagnosing conditions related to hypoxia.
|
WO2011158243A2
(en)
|
2010-06-16 |
2011-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of diagnosing and treating cancer
|
CN103154022A
(en)
|
2010-06-16 |
2013-06-12 |
富途锐基尼以色列有限公司 |
Pest-resistant plants
|
ES2817780T3
(en)
|
2010-07-12 |
2021-04-08 |
The State Of Israel Ministry Of Agriculture And Rural Development Agricultural Res Organization A R |
Isolated polynucleotides and methods and plants that use them to regulate the acidity of plants
|
WO2012007919A2
(en)
|
2010-07-15 |
2012-01-19 |
Technion Research & Development Foundation Ltd. |
Nucleic acid construct for increasing abiotic stress tolerance in plants
|
US9695410B2
(en)
|
2010-07-15 |
2017-07-04 |
Technion Research & Development Foundation Limited |
Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides
|
EP2593480A2
(en)
|
2010-07-15 |
2013-05-22 |
Technion Research & Development Foundation Ltd. |
Antibodies with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
|
WO2012011113A2
(en)
|
2010-07-22 |
2012-01-26 |
Shai Yarkoni |
Regulatory immune cells with enhanced targeted cell death effect
|
US9144585B2
(en)
|
2010-07-27 |
2015-09-29 |
Technion Research & Development Foundation Limited |
Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
|
WO2012014208A2
(en)
|
2010-07-27 |
2012-02-02 |
Yeda Research And Development Co. Ltd. |
Methods and systems for assessing clonality of cell cultures
|
WO2012014207A2
(en)
|
2010-07-27 |
2012-02-02 |
Technion Research & Development Foundation Ltd. |
Method for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
|
WO2012017439A2
(en)
|
2010-08-04 |
2012-02-09 |
Ramot At Tel-Aviv University Ltd. |
Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
|
WO2012025914A1
(en)
|
2010-08-22 |
2012-03-01 |
Ramot At Tel-Aviv University Ltd. |
Induced pluripotent stem cells derived from human pancreatic beta cells
|
WO2012025925A1
(en)
|
2010-08-24 |
2012-03-01 |
Rappaport Family Institute For Research In The Medical Sciences |
Methods of improving transplantation using sdf-1alpha
|
CA3158003A1
(en)
|
2010-08-30 |
2012-03-08 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and/or abiotic stress tolerance
|
WO2012032510A1
(en)
|
2010-09-07 |
2012-03-15 |
Yeda Research And Development Co. Ltd. |
Primers for amplifying dna and methods of selecting same
|
ES2746482T3
(en)
|
2010-09-07 |
2020-03-06 |
Technion Res & Dev Foundation |
New methods and culture media to cultivate pluripotent stem cells
|
WO2012032519A2
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of diagnosing parkinson's disease
|
WO2012032520A1
(en)
|
2010-09-07 |
2012-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
|
US20130183322A1
(en)
|
2010-09-08 |
2013-07-18 |
Yeda Research And Development Co., Ltd. |
Immunosuppressive drug combination for a stable and long term engraftment
|
JP5977238B2
(en)
|
2010-09-08 |
2016-08-24 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
Use of anti-third party central memory T cells for anti-leukemia / lymphoma treatment
|
WO2012035539A1
(en)
|
2010-09-15 |
2012-03-22 |
Ramot At Tel-Aviv University Ltd. |
Methods of expanding and redifferentiating islet beta cells
|
US20130210901A1
(en)
|
2010-09-20 |
2013-08-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of treating neurodegenerative diseases
|
WO2012052872A2
(en)
|
2010-10-17 |
2012-04-26 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for the treatment of insulin-associated medical conditions
|
WO2012052878A1
(en)
|
2010-10-19 |
2012-04-26 |
Vascular Biogenics Ltd. |
Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
|
WO2012056452A2
(en)
|
2010-10-27 |
2012-05-03 |
Nanocyte (Israel) Ltd. |
Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
|
WO2012056455A1
(en)
|
2010-10-28 |
2012-05-03 |
Yeda Research And Development Co. Ltd. |
Methods of generating antibodies to metalloenzymes
|
UY33705A
(en)
|
2010-11-03 |
2012-04-30 |
Yissum Res Dev Co |
TRANSGENIC PLANTS WITH IMPROVED SACARIFICATION PERFORMANCES AND METHODS TO GENERATE THEM
|
US9410132B2
(en)
|
2010-11-04 |
2016-08-09 |
Ben-Gurion University Of The Negev Research And Development Authority |
Acyl-CoA: diacylglycerol acyltransferase 1-like gene (PtDGAT1) and uses thereof
|
AR083885A1
(en)
|
2010-11-15 |
2013-03-27 |
Univ Ramot |
ANALOGS OF DIPEPTIDES FOR THE TREATMENT OF AFFECTIONS ASSOCIATED WITH THE FORMATION OF AMILOID FIBRILLES
|
WO2012066495A2
(en)
|
2010-11-17 |
2012-05-24 |
Ben Gurion University Of The Negev Research And Development Authority |
T-cell therapy to neurodegenerative diseases
|
WO2012073238A1
(en)
|
2010-12-02 |
2012-06-07 |
Technion Research & Development Foundation Ltd. |
Methods of generating corneal cells and cell populations comprising same
|
US20120183960A1
(en)
|
2010-12-07 |
2012-07-19 |
Enterologics, Inc. |
Method for identifying e. coli m-17
|
JP5922147B2
(en)
|
2010-12-15 |
2016-05-24 |
カディマステム リミテッド |
Insulin-producing cells derived from pluripotent stem cells
|
CA3095614A1
(en)
|
2010-12-22 |
2012-06-28 |
Evogene Ltd. |
Isolated polynucleotides and polypeptides, and methods of using same for increasing abiotic stress tolerance, yield, growth rate, vigor, biomass, oil content, and/or nitrogen use efficiency of plants
|
BR112013016535A2
(en)
|
2010-12-28 |
2016-09-20 |
Bio Fd&C Co Ltd |
plant extracts for the treatment and prevention of infections
|
EP2665814B1
(en)
|
2011-01-20 |
2017-05-17 |
Protalix Ltd. |
Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
|
WO2012104851A1
(en)
|
2011-01-31 |
2012-08-09 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing disease using overlap extension pcr
|
US20130330349A1
(en)
|
2011-02-23 |
2013-12-12 |
Rappaport Family Institute For Research In The Medical Sciences |
High affinity molecules capable of binding a type a plexin receptor and uses of same
|
UA113843C2
(en)
|
2011-03-02 |
2017-03-27 |
|
BACTERIA TRANSGENIC PLANT CONTAINING T3SS DIFFUNCTIONAL PROTEINS
|
EP2680864B1
(en)
|
2011-03-03 |
2019-05-08 |
Ramot at Tel-Aviv University Ltd. |
Genetically modified muscle cells which express neurotrophic factors
|
CN103597073B
(en)
|
2011-03-06 |
2019-06-07 |
默克雪兰诺有限公司 |
Low fucose cell line and its application
|
WO2012120518A1
(en)
|
2011-03-08 |
2012-09-13 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for diagnosing and treating phenylketonuria (pku)
|
US9624291B2
(en)
|
2011-03-17 |
2017-04-18 |
Ramot At Tel-Aviv University Ltd. |
Bi- and monospecific, asymmetric antibodies and methods of generating the same
|
CN103533934B
(en)
|
2011-03-17 |
2016-03-30 |
特尔汗什莫尔医学基础设施研究和服务公司 |
Be used for the treatment of the quinolone analogs of autoimmune disease
|
KR101903339B1
(en)
|
2011-03-22 |
2018-10-01 |
플루리스템 리미티드 |
Methods for treating radiation or chemical injury
|
SG193418A1
(en)
|
2011-03-24 |
2013-10-30 |
Neurim Pharma 1991 |
Neuroprotective peptides
|
WO2012131680A2
(en)
|
2011-03-28 |
2012-10-04 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating inflammation
|
WO2012137202A1
(en)
|
2011-04-05 |
2012-10-11 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
|
JP5990254B2
(en)
|
2011-04-06 |
2016-09-07 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッドRamot At Tel Aviv University Ltd. |
Methods for monitoring and analyzing metabolic activity profiles and their diagnostic and therapeutic uses
|
WO2012142164A1
(en)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
|
AU2012241521B2
(en)
|
2011-04-15 |
2016-07-14 |
Pluri Biotech Ltd |
Methods and systems for harvesting cells
|
AR086243A1
(en)
|
2011-05-03 |
2013-11-27 |
Evogene Ltd |
POLYPEPTIDES AND POLINUCLEOTIDES ISOLATED AND METHODS FOR USE, TO INCREASE PERFORMANCE, BIOMASS, GROWTH INDEX, VIGOR, OIL CONTENT, TOLERANCE TO THE ABIOTIC STRESS OF PLANTS AND EFFICIENCY IN THE USE OF THE NITER
|
EP2704793B1
(en)
|
2011-05-04 |
2019-07-17 |
Ramot at Tel Aviv University, Ltd. |
Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
|
WO2012153333A1
(en)
|
2011-05-09 |
2012-11-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Regeneration and repair of mesenchymal tissue using amelogenin
|
WO2012153336A2
(en)
|
2011-05-12 |
2012-11-15 |
Rakuto Bio Technologies Ltd. |
Methods and device for lightening skin complexion
|
WO2012156976A1
(en)
|
2011-05-16 |
2012-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of producing artemisinin in non-host plants and vectors for use in same
|
WO2012160526A2
(en)
|
2011-05-23 |
2012-11-29 |
Ofir Menashe |
Formulations of microorganism comprising particles and uses of same
|
US20140088017A1
(en)
|
2011-05-23 |
2014-03-27 |
Yeda Research And Development Co., Ltd. |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
CN107325164A
(en)
|
2011-05-31 |
2017-11-07 |
和黄生物膜医疗解决方案有限公司 |
The scattered and disengaging of cell aggregation
|
WO2012164565A1
(en)
|
2011-06-01 |
2012-12-06 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for downregulating prokaryotic genes
|
US10166295B2
(en)
|
2011-06-02 |
2019-01-01 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
EP2720720B1
(en)
|
2011-06-14 |
2018-02-28 |
Yeda Research and Development Co. Ltd. |
Combination therapy to prevent dcis formation and progression to breast cancer
|
AR086989A1
(en)
|
2011-06-23 |
2014-02-05 |
Kaiima Bio Agritech Ltd |
COMMON WHEAT: ITS PLANTS OR PARTS THAT HAVE A PARTIAL OR COMPLETELY MULTIPLIED GENOME, THEIR HYBRIDS AND PRODUCTS AND METHODS TO GENERATE AND USE THEM
|
EP2734036A1
(en)
|
2011-07-20 |
2014-05-28 |
Kaiima Bio Agritech Ltd. |
Maize plants having a partially or fully multiplied genome and uses thereof
|
US20130030452A1
(en)
|
2011-07-27 |
2013-01-31 |
Health Corporation - Rambam |
Devices for surgical applications
|
BR112014002737B1
(en)
|
2011-08-04 |
2022-08-02 |
Yeda Research And Development Co. Ltd. |
MIR-135
|
US9499793B2
(en)
|
2011-08-09 |
2016-11-22 |
Yeda Research And Development Co. Ltd. |
Downregulation of miR-7 for promotion of beta cell differentiation and insulin production
|
MX2014001777A
(en)
|
2011-08-14 |
2014-08-21 |
Kaiima Bio Agritech Ltd |
Durum wheat plants having a partially or fully multiplied genome and uses thereof.
|
US9959392B2
(en)
|
2011-09-07 |
2018-05-01 |
Yeda Research And Development Co. Ltd. |
Olfactory signature and odorant mixture having the same
|
AU2012305931B2
(en)
|
2011-09-08 |
2017-09-07 |
Yeda Research And Development Co. Ltd |
Anti third party central memory T cells, methods of producing same and use of same in transplantation and disease treatment
|
ES2657552T3
(en)
|
2011-09-08 |
2018-03-05 |
Yeda Research And Development Co. Ltd. |
New risk biomarkers for lung cancer
|
US10760086B2
(en)
|
2011-09-13 |
2020-09-01 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP3382027A3
(en)
|
2011-09-13 |
2018-10-31 |
Monsanto Technology LLC |
Methods and compositions for weed control
|
US10829828B2
(en)
|
2011-09-13 |
2020-11-10 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
EP2755466A4
(en)
|
2011-09-13 |
2015-04-15 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
CA2848695A1
(en)
|
2011-09-13 |
2013-03-21 |
Monsanto Technology Llc |
Methods and composition for weed control comprising inhibiting ppg oxidase
|
US10806146B2
(en)
|
2011-09-13 |
2020-10-20 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
CN103957697B
(en)
|
2011-09-13 |
2017-10-24 |
孟山都技术公司 |
Method and composition for Weeds distribution
|
WO2013054320A1
(en)
|
2011-10-11 |
2013-04-18 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
|
WO2013056377A1
(en)
|
2011-10-21 |
2013-04-25 |
Augurex Life Sciences Corporation |
Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
|
US9145559B2
(en)
|
2011-10-27 |
2015-09-29 |
Yeda Research And Development Co. Ltd. |
Methods of treating cancer
|
SG11201401648RA
(en)
|
2011-11-03 |
2014-05-29 |
Quark Pharmaceuticals Inc |
Methods and compositions for neuroprotection
|
WO2013070821A1
(en)
|
2011-11-08 |
2013-05-16 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
US9736998B2
(en)
|
2011-11-23 |
2017-08-22 |
Danziger Dan Flower Farm |
Otomeria plants
|
US9617331B2
(en)
|
2011-11-27 |
2017-04-11 |
Yeda Research And Development Co. Ltd. |
Methods of regulating angiogenesis by administering agents which increase apoB-100 polypeptide
|
EP3034087B1
(en)
|
2011-12-08 |
2018-03-14 |
Yeda Research and Development Co. Ltd. |
Mammalian fetal pulmonary cells and therapeutic use of same
|
WO2013093921A1
(en)
|
2011-12-20 |
2013-06-27 |
Collplant Ltd. |
Collagen coated synthetic polymer fibers
|
CN105833925B
(en)
|
2011-12-22 |
2018-11-13 |
瑞尔比奥技术有限公司 |
sequential lateral flow capillary device for analyte determination
|
DK2797421T3
(en)
|
2011-12-22 |
2020-08-24 |
Yeda Res & Dev |
A COMBINATION THERAPY FOR A STABLE AND LONG-TERM TRANSPLANTATION USING SPECIFIC PROTOCOLS FOR T / BCELLE DISCHARGE
|
US20150013029A1
(en)
|
2011-12-28 |
2015-01-08 |
Kaiima Bio Agritech Ltd. |
Cultivated sorghum plant having a partially or fully multiplied genome and uses of same
|
US20150216998A1
(en)
|
2012-01-01 |
2015-08-06 |
Ramot At Tel-Aviv University Ltd. |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
WO2013114363A2
(en)
|
2012-01-30 |
2013-08-08 |
Yeda Research And Development Co.Ltd. |
Antimicrobial agents
|
WO2013114371A1
(en)
|
2012-02-01 |
2013-08-08 |
Protalix Ltd. |
Dry powder formulations of dnase i
|
US10184131B2
(en)
|
2012-02-06 |
2019-01-22 |
A.B. Seeds Ltd. |
Isolated polynucleotides expressing or modulating microRNAs or targets of same, transgenic plants comprising same and uses thereof
|
WO2013121426A1
(en)
|
2012-02-13 |
2013-08-22 |
Gamida-Cell Ltd. |
Culturing of mesenchymal stem cells
|
EA028578B1
(en)
|
2012-02-14 |
2017-12-29 |
Опко Байолоджикс Лтд. |
Long-acting coagulation factors and methods of producing same
|
CN104245725A
(en)
|
2012-02-19 |
2014-12-24 |
波塔力克斯有限公司 |
Oral unit dosage forms and uses of same for the treatment of gaucher disease
|
US10034902B2
(en)
|
2012-02-22 |
2018-07-31 |
Exostem Biotec Ltd. |
MicroRNAs for the generation of astrocytes
|
JP2015509366A
(en)
|
2012-02-22 |
2015-03-30 |
ブレインステム バイオテック リミテッド |
Generation of neural stem cells and motor neurons
|
EP2833714A1
(en)
|
2012-03-01 |
2015-02-11 |
The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
|
EP3483184A1
(en)
|
2012-03-07 |
2019-05-15 |
Yeda Research and Development Co. Ltd |
Compositions for inhibition of quiescinsulfhydryl oxidase (qsox1) and uses of same
|
US9334308B2
(en)
|
2012-03-22 |
2016-05-10 |
Ramot At Tel-Aviv University Ltd. |
PLIF multimeric peptides and uses thereof
|
US9925143B2
(en)
|
2012-04-18 |
2018-03-27 |
Ramot At Tel-Aviv University Ltd. |
Lipidated glycosaminoglycan particles for the delivery of nucleic acids
|
US9522945B2
(en)
|
2012-04-19 |
2016-12-20 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin variants and methods of producing same
|
WO2013160895A1
(en)
|
2012-04-24 |
2013-10-31 |
Biokine Therapeutics Ltd. |
Peptides and use thereof in the treatment of large cell lung cancer
|
US9764008B2
(en)
|
2012-05-09 |
2017-09-19 |
Yeda Research And Development Co. Ltd. |
Variants of TACE pro-domain as TNF-A inhibitor and their medical use
|
US8865158B2
(en)
|
2012-05-22 |
2014-10-21 |
Ramot At Tel-Aviv University Ltd. |
Bacteriophages for reducing toxicity of bacteria
|
CN104603149B
(en)
|
2012-05-24 |
2017-06-30 |
万机集团有限公司 |
The composition related to prevention and treatment rabies infection and method
|
AU2013264742B2
(en)
|
2012-05-24 |
2018-10-04 |
A.B. Seeds Ltd. |
Compositions and methods for silencing gene expression
|
EP2855507B1
(en)
|
2012-06-03 |
2018-01-03 |
Ben-Gurion University of The Negev Research and Development Authority |
Functionalized titanium binding peptides and implants coated with same
|
AU2013273135B2
(en)
|
2012-06-04 |
2017-12-07 |
Opko Biologics Ltd. |
Pegylated OXM variants
|
WO2014006621A1
(en)
|
2012-07-03 |
2014-01-09 |
Nanospun Technologies Ltd. |
Methods and devices for adsorption and biodegradation of petroleum
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
DK2880155T3
(en)
|
2012-07-29 |
2019-07-15 |
Yeda Res & Dev |
USE OF THE REDUCING GLYCINE ROAD FOR GENERATING FORMATOTROPHIC AND AUTOTROPHIC MICRO-ORGANISMS
|
JP6340366B2
(en)
|
2012-07-31 |
2018-06-06 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
Methods for diagnosing and treating motor neuron disease
|
EP2880151B1
(en)
|
2012-08-06 |
2020-06-03 |
Brainstorm Cell Therapeutics Ltd. |
Methods of generating mesenchymal stem cells which secrete neurotrophic factors
|
US20140068814A1
(en)
|
2012-09-03 |
2014-03-06 |
A.B. Seeds Ltd. |
Method of improving abiotic stress tolerance of plants and plants generated thereby
|
EP2895197B1
(en)
|
2012-09-12 |
2020-02-26 |
Ramot at Tel-Aviv University Ltd. |
Immunoparticles and methods of generating and using same
|
EP2906954B1
(en)
|
2012-10-09 |
2018-04-11 |
Ramot at Tel-Aviv University Ltd. |
Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
|
EP2908864B1
(en)
|
2012-10-22 |
2019-12-11 |
Sabag-Rfa Ltd. |
Phosphate compounds for delivering therapeutic agents into living cells and cells nuclei
|
WO2014064682A1
(en)
|
2012-10-24 |
2014-05-01 |
Yeda Research And Development Co. Ltd. |
Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
|
EP2912181B1
(en)
|
2012-10-29 |
2017-11-29 |
Yeda Research and Development Co., Ltd. |
Aptamers, multimeric aptamers and uses thereof
|
CN114317505A
(en)
|
2012-11-20 |
2022-04-12 |
奥普科生物制品有限公司 |
Method for increasing the hydrodynamic volume of a polypeptide by attachment to a gonadotrophin carboxy terminal peptide
|
US20150290233A1
(en)
|
2012-11-29 |
2015-10-15 |
Yeda Research And Development Co.Ltd. At The Weizmann Institute Of Science |
Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
|
WO2015079413A2
(en)
|
2013-11-28 |
2015-06-04 |
Yeda Research And Development Co. Ltd. |
Synaptojanin-2 inhibitors and uses thereof
|
US10683505B2
(en)
|
2013-01-01 |
2020-06-16 |
Monsanto Technology Llc |
Methods of introducing dsRNA to plant seeds for modulating gene expression
|
BR112015015976A2
(en)
|
2013-01-01 |
2018-04-10 |
A. B. Seeds Ltd. |
method for introducing dsrna into seeds to modulate gene expression
|
WO2014108850A2
(en)
|
2013-01-09 |
2014-07-17 |
Yeda Research And Development Co. Ltd. |
High throughput transcriptome analysis
|
WO2014108854A1
(en)
|
2013-01-09 |
2014-07-17 |
Fusimab Ltd. |
Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
|
ES2681425T3
(en)
|
2013-01-17 |
2018-09-13 |
Novellusdx Ltd. |
Methods and systems for the identification of specific conductive mutations
|
US10000737B2
(en)
|
2013-02-04 |
2018-06-19 |
Ramot At Tel-Aviv University Ltd. |
Generation of cytotoxic tumor specific cell lines and uses thereof
|
CA2902727C
(en)
|
2013-03-06 |
2020-08-18 |
Protalix Ltd. |
Use of plant cells expressing a tnfalpha polypeptide inhibitor in therapy
|
WO2014136113A1
(en)
|
2013-03-06 |
2014-09-12 |
Protalix Ltd. |
Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
|
WO2014164761A1
(en)
|
2013-03-13 |
2014-10-09 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
MX2015012334A
(en)
|
2013-03-13 |
2016-02-05 |
Monsanto Technology Llc |
Methods and compositions for weed control.
|
US10568328B2
(en)
|
2013-03-15 |
2020-02-25 |
Monsanto Technology Llc |
Methods and compositions for weed control
|
CN105263511A
(en)
|
2013-03-21 |
2016-01-20 |
科尔普兰特有限公司 |
Compositions comprising collagen and PRP for tissue regeneration
|
BR112015024558A2
(en)
|
2013-03-24 |
2017-07-18 |
Biokine Therapeutics Ltd |
method for treating myeloid leukemia.
|
WO2014174511A1
(en)
|
2013-04-21 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Agents for downregulation of the activity and/or amount of bcl-xl and/or bcl-w
|
CN105531365A
(en)
|
2013-04-23 |
2016-04-27 |
耶达研究及发展有限公司 |
Isolated naive pluripotent stem cells and methods of generating same
|
WO2014174520A1
(en)
|
2013-04-25 |
2014-10-30 |
Yeda Research And Development Co. Ltd. |
Use of inhibitory peptides for the treatment of inflammatory diseases
|
US20160115231A1
(en)
|
2013-05-21 |
2016-04-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mast cell related pathologies
|
RU2015151047A
(en)
|
2013-05-27 |
2017-06-29 |
Ракуто Био Текнолоджис Лтд. |
COSMETIC COMPOSITIONS CONTAINING AN ENZYME SYSTEM
|
WO2014207744A1
(en)
|
2013-06-24 |
2014-12-31 |
Ramot At Tel-Aviv University Ltd. |
Omentum based scaffold and delivery system
|
US9850496B2
(en)
|
2013-07-19 |
2017-12-26 |
Monsanto Technology Llc |
Compositions and methods for controlling Leptinotarsa
|
EP3030663B1
(en)
|
2013-07-19 |
2019-09-04 |
Monsanto Technology LLC |
Compositions and methods for controlling leptinotarsa
|
WO2015015489A1
(en)
|
2013-07-30 |
2015-02-05 |
Biolinerx Ltd. |
Antibody for treating diabetes and autoimmune diseases
|
CN105849117B
(en)
|
2013-08-29 |
2017-12-12 |
耶达研究及发展有限公司 |
The selective depressant of the hypotypes of α 2 of Na, K ATP enzyme and the purposes for reducing intraocular pressure
|
US20160251410A1
(en)
|
2013-09-03 |
2016-09-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for expressing recombinant polypeptides
|
IL228284A
(en)
|
2013-09-03 |
2016-12-29 |
Technion Res & Dev Foundation |
Implants composed of cellular scaffolds and a vascular pedicle
|
WO2015033344A1
(en)
|
2013-09-05 |
2015-03-12 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
|
WO2015037009A1
(en)
|
2013-09-16 |
2015-03-19 |
Plexicure Ltd. |
Isolated proteins capable of binding plexin-a4 and methods of producing and using same
|
WO2015040609A1
(en)
|
2013-09-17 |
2015-03-26 |
Yeda Research And Development Co. Ltd. |
Erk-derived peptides and uses thereof
|
EP3052191B1
(en)
|
2013-10-01 |
2020-03-18 |
Kadimastem Ltd. |
Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of amyotrophic lateral sclerosis (als)
|
DK3060239T3
(en)
|
2013-10-21 |
2020-08-03 |
Opko Biologics Ltd |
LONG-TERM POLICPTIDES AND METHODS OF MANUFACTURE AND SUBMISSION
|
US20150158926A1
(en)
|
2013-10-21 |
2015-06-11 |
Opko Biologics, Ltd. |
Long-acting polypeptides and methods of producing and administering same
|
WO2015059690A1
(en)
|
2013-10-24 |
2015-04-30 |
Yeda Research And Development Co. Ltd. |
Polynucleotides encoding brex system polypeptides and methods of using s ame
|
EP3062809B1
(en)
|
2013-10-31 |
2020-07-08 |
Biokine Therapeutics Ltd. |
A cxcr4 peptide inhibitor for use in treating acute myeloid leukemia with a flt3 mutation
|
EP3066200A1
(en)
|
2013-11-04 |
2016-09-14 |
Monsanto Technology LLC |
Compositions and methods for controlling arthropod parasite and pest infestations
|
EP3074391B1
(en)
|
2013-11-28 |
2019-07-31 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Rna polymerase i inhibitors and uses thereof
|
UA119253C2
(en)
|
2013-12-10 |
2019-05-27 |
Біолоджикс, Інк. |
Compositions and methods for virus control in varroa mite and bees
|
ES2697757T3
(en)
|
2013-12-10 |
2019-01-28 |
Yeda Res & Dev |
Use of enzymes that catalyze the synthesis of pyruvate from formate and acetyl-CoA and bacteria that express the same
|
UA121462C2
(en)
|
2014-01-15 |
2020-06-10 |
Монсанто Текнолоджі Елелсі |
Methods and compositions for weed control using epsps polynucleotides
|
WO2015114633A1
(en)
|
2014-01-30 |
2015-08-06 |
Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. |
Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same
|
JP2017506259A
(en)
|
2014-02-03 |
2017-03-02 |
イッスム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッドYissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Use of casein kinase I inhibitors to deplete stem cells
|
CA2936158C
(en)
|
2014-02-05 |
2023-06-13 |
Yeda Research And Development Co. Ltd. |
Use of mir-135 or precursor thereof for the treatment and diagnosis of a bipolar disease
|
CN106573976B
(en)
|
2014-02-06 |
2020-05-05 |
耶达研究及发展有限公司 |
anti-CD 84 antibodies, compositions comprising the antibodies, and uses thereof
|
US20170101633A1
(en)
|
2014-02-10 |
2017-04-13 |
Protalix Ltd. |
Method of maintaining disease stability in a subject having gaucher's disease
|
BR112016018489A2
(en)
|
2014-02-11 |
2017-08-08 |
Brainstorm Cell Therapeutics Ltd |
MESENCHYMAL STEM CELL METHOD OF QUALIFICATION, ISOLATED POPULATION OF MESENCHYMAL STEM CELLS, METHOD OF TREATMENT OF AN IMMUNE OR INFLAMMATORY DISEASE, AND USE OF MESENCHYMAL STEM CELLS
|
CN106255882A
(en)
|
2014-03-03 |
2016-12-21 |
耶路撒冷希伯来大学伊森姆研究发展公司 |
For the method and apparatus detecting Pseudomonas aeruginosa
|
EP2923709A1
(en)
|
2014-03-28 |
2015-09-30 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Multi-component-multistage malaria vaccine
|
US11091770B2
(en)
|
2014-04-01 |
2021-08-17 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
EP3129075A4
(en)
|
2014-04-10 |
2017-12-06 |
Bonus Therapeutics Ltd. |
Bone repair compositions
|
FI4026917T3
(en)
|
2014-04-14 |
2024-02-14 |
Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd |
A method and kit for determining the death of cells or tissue or the tissue or cell origin of dna by dna methylation analysis
|
US10590467B2
(en)
|
2014-04-17 |
2020-03-17 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing DNA binding moieties attached to DNA
|
CR20160534A
(en)
|
2014-04-27 |
2017-04-25 |
Ccam Biotherapeutics Ltd |
HUMANIZED ANTIBODIES AGAINST THE CELLULAR ADHESION MOLECULE RELATED TO CARCINOEMBRIONIC ANTIGEN 1 (CEACAM1)
|
US11427647B2
(en)
|
2014-04-27 |
2022-08-30 |
Famewave Ltd. |
Polynucleotides encoding humanized antibodies against CEACAM1
|
CN106460048B
(en)
|
2014-04-28 |
2021-01-05 |
耶达研究及发展有限公司 |
Microbiome response to agents
|
EP3140405A2
(en)
|
2014-05-04 |
2017-03-15 |
Forrest Innovations Ltd. |
Compositions and methods for reducing pathogen-induced citrus greening
|
WO2015177800A2
(en)
|
2014-05-22 |
2015-11-26 |
Yeda Research And Development Co. Ltd. |
Recombinant microorganisms capable of carbon fixation
|
US20170253881A1
(en)
|
2014-06-02 |
2017-09-07 |
Technion Research & Development Foundation Limited |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
US20170095512A1
(en)
|
2014-06-02 |
2017-04-06 |
Kadimastem Ltd. |
Methods of inducing myelination and maturation of oligodendrocytes
|
AU2015280252A1
(en)
|
2014-06-23 |
2017-01-12 |
Monsanto Technology Llc |
Compositions and methods for regulating gene expression via RNA interference
|
EP3145951A1
(en)
|
2014-06-24 |
2017-03-29 |
InSight Biopharmaceuticals Ltd. |
Methods of purifying antibodies
|
US11807857B2
(en)
|
2014-06-25 |
2023-11-07 |
Monsanto Technology Llc |
Methods and compositions for delivering nucleic acids to plant cells and regulating gene expression
|
CN106537148B
(en)
|
2014-06-25 |
2019-10-11 |
泰尔哈绍梅尔医学研究基础设施和服务有限公司 |
Cancer stem cell identification and its for diagnosing and treating purposes
|
JP2017520549A
(en)
|
2014-06-26 |
2017-07-27 |
ラモット アット テル アビブ ユニバーシティ, リミテッド |
Liposome formulation for delivery of nucleic acids
|
WO2016005985A2
(en)
|
2014-07-09 |
2016-01-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reprogramming cells
|
AU2015291151B2
(en)
|
2014-07-15 |
2019-10-10 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Isolated polypeptides of CD44 and uses thereof
|
CN107076727B
(en)
|
2014-07-21 |
2019-11-01 |
诺威尔卢斯德克有限公司 |
For determining the method and system of the carcinogenic index of patient's specific mutation
|
CA2955411A1
(en)
|
2014-07-21 |
2016-01-28 |
Novellusdx Ltd. |
Methods for determining drug response of patient specific mutations
|
CA2955842A1
(en)
|
2014-07-29 |
2016-02-04 |
Monsanto Technology Llc |
Compositions and methods for controlling insect pests
|
JP2017525351A
(en)
|
2014-07-30 |
2017-09-07 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
Culture medium for pluripotent stem cells
|
AU2015302870B2
(en)
|
2014-08-14 |
2021-12-23 |
Memed Diagnostics Ltd. |
Computational analysis of biological data using manifold and a hyperplane
|
WO2016030899A1
(en)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral scleroses
|
CA2959716A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Anti-her3 antibodies and uses of same
|
EP2992895A1
(en)
|
2014-09-08 |
2016-03-09 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Three-component-multistage malaria vaccine
|
WO2016038610A1
(en)
|
2014-09-08 |
2016-03-17 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for treating cancer resistant to a tyrosine kinase inhibitor (tki)
|
IL234638A0
(en)
|
2014-09-14 |
2014-12-02 |
Yeda Res & Dev |
Nmda receptor antagonists for treating gaucher disease
|
US10174320B2
(en)
|
2014-09-21 |
2019-01-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Downregulating miR-132 for the treatment of lipid related disorders
|
JP6767374B2
(en)
|
2014-10-20 |
2020-10-14 |
ジェン−プローブ・インコーポレーテッド |
Red blood cell lysing solution
|
US10570368B2
(en)
|
2014-11-13 |
2020-02-25 |
Enzootic Holdings Ltd. |
Functional sex-reversal of decapod crustacean females
|
EP3220945A2
(en)
|
2014-11-17 |
2017-09-27 |
Yeda Research and Development Co., Ltd. |
Methods of treating diseases related to mitochondrial function
|
EP3221470B1
(en)
|
2014-11-17 |
2019-08-14 |
Yeda Research and Development Co., Ltd. |
Method of analyzing microbiome
|
WO2016079739A2
(en)
|
2014-11-20 |
2016-05-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
|
WO2016084088A1
(en)
|
2014-11-26 |
2016-06-02 |
Ramot At Tel-Aviv University Ltd. |
Targeted elimination of bacterial genes
|
WO2016084084A1
(en)
|
2014-11-27 |
2016-06-02 |
Danziger Innovations Ltd. |
Nucleic acid constructs for genome editing
|
WO2016092555A2
(en)
|
2014-12-11 |
2016-06-16 |
Yeda Research And Development Co. Ltd. |
Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
|
WO2016103269A1
(en)
|
2014-12-23 |
2016-06-30 |
Ramot At Tel-Aviv University Ltd. |
Populations of neural progenitor cells and methods of producing and using same
|
US11891622B2
(en)
|
2014-12-30 |
2024-02-06 |
Cell Cure Neurosciences Ltd. |
RPE cell populations and methods of generating same
|
AU2015373051B2
(en)
|
2014-12-30 |
2022-10-06 |
Cell Cure Neurosciences Ltd. |
Assessing retinal pigment epithelial cell populations
|
US20180008458A1
(en)
|
2014-12-30 |
2018-01-11 |
Cell Cure Neurosciences Ltd. |
Methods of treating retinal diseases
|
AU2016204793B2
(en)
|
2015-01-04 |
2021-12-16 |
Protalix Ltd. |
Modified DNase and uses thereof
|
WO2016116935A1
(en)
|
2015-01-21 |
2016-07-28 |
Yeda Research And Development Co. Ltd. |
Use of rasa2 as a prognostic and therapeutic marker for melanoma
|
PL3256589T3
(en)
|
2015-01-22 |
2022-02-21 |
Monsanto Technology Llc |
Compositions and methods for controlling leptinotarsa
|
EP3261612A1
(en)
|
2015-02-26 |
2018-01-03 |
Yeda Research and Development Co. Ltd |
Method of promoting hair growth
|
EP3268475B1
(en)
|
2015-03-11 |
2020-10-21 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Decoy oligonucleotides for the treatment of diseases
|
IL237852A0
(en)
|
2015-03-19 |
2016-03-24 |
Yeda Res & Dev |
Anti amphiregulin antibodies, compositions comprising same and uses thereof
|
WO2016160618A2
(en)
|
2015-03-27 |
2016-10-06 |
University Of Southern California |
Car t-cell therapy directed to lhr for the treatment of solid tumors
|
EP4218771A1
(en)
|
2015-03-27 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Methods of treating motor neuron diseases
|
JP2018511325A
(en)
|
2015-03-31 |
2018-04-26 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
Glutamate oxaloacetate transaminase 1 (GOT1), its preparation and production method and use thereof
|
EP3277260B1
(en)
|
2015-04-01 |
2021-05-12 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Erodium crassifolium l'her plant extracts and uses thereof
|
JP2018515597A
(en)
|
2015-04-07 |
2018-06-14 |
イーエルエイ ファーマ リミテッドEla Pharma Ltd |
Composition for the treatment and / or prevention of cell and / or tissue necrosis specifically targeting cathepsin C and / or CELA1 and / or CELA3A and / or enzymes structurally related thereto
|
EP3081575A1
(en)
|
2015-04-12 |
2016-10-19 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Anti-plasmodium parasite antibodies
|
WO2016174674A1
(en)
|
2015-04-27 |
2016-11-03 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Egr1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
|
CA2984202A1
(en)
|
2015-04-29 |
2016-11-03 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Anti-phytopathogenic compositions
|
WO2016174652A1
(en)
|
2015-04-30 |
2016-11-03 |
Technion Research & Development Foundation Limited |
Chimeric antigen receptors and methods of their use
|
US11845928B2
(en)
|
2015-05-04 |
2023-12-19 |
Tsinghua University |
Methods and kits for fragmenting DNA
|
WO2016181393A1
(en)
|
2015-05-11 |
2016-11-17 |
Yeda Research And Development Co. Ltd. |
Citrin inhibitors for the treatment of cancer
|
EP3298141A4
(en)
|
2015-05-17 |
2019-01-09 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Compositions and methods for treating cancer
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
US10849985B2
(en)
|
2015-05-20 |
2020-12-01 |
Yeda Research And Development Co. Ltd. |
Method of targeting senescent cells
|
US20180140648A1
(en)
|
2015-05-21 |
2018-05-24 |
Yeda Research And Development Co. Ltd. |
Bacterial populations for promoting health
|
AU2016273045B2
(en)
|
2015-05-29 |
2020-11-26 |
Opko Biologics Ltd. |
Pegylated oxyntomodulin variants
|
EP3302053B1
(en)
|
2015-06-02 |
2021-03-17 |
Monsanto Technology LLC |
Compositions and methods for delivery of a polynucleotide into a plant
|
EP3302030A4
(en)
|
2015-06-03 |
2019-04-24 |
Monsanto Technology LLC |
Methods and compositions for introducing nucleic acids into plants
|
JP7010473B2
(en)
|
2015-06-04 |
2022-02-10 |
ユニバーシティ オブ サザン カリフォルニア |
LYM-1 and LYM-2 Targeted CAR Cell Immunotherapy
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
EP3310388B1
(en)
|
2015-06-18 |
2021-10-06 |
Yeda Research and Development Co., Ltd. |
Conditioning protocols and use of same for tissue regeneration
|
WO2016203476A1
(en)
|
2015-06-18 |
2016-12-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods and compositions for diagnosing and treating urothelial cancer
|
CN113289009A
(en)
|
2015-06-19 |
2021-08-24 |
Opko生物科学有限公司 |
Long-acting coagulation factor and production method thereof
|
JP7057748B2
(en)
|
2015-07-16 |
2022-04-20 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッド |
Genetically modified anti-third party central memory T cells and their use in immunotherapy
|
CN111375066B
(en)
|
2015-07-16 |
2023-04-25 |
百欧肯治疗有限公司 |
Compositions and methods for treating cancer
|
EP3325494B1
(en)
|
2015-07-19 |
2020-12-30 |
Yeda Research and Development Co., Ltd. |
Selective inhibitors of alpha2-containing isoforms of na,k-atpase and use thereof for reducing intraocular pressure
|
PT3324754T
(en)
|
2015-07-22 |
2022-11-30 |
Phytopharma Int Ltd |
Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby
|
JP7055095B2
(en)
|
2015-07-29 |
2022-04-15 |
ハダシット メディカル リサーチ サービシーズ アンド ディベロップメント リミテッド |
Large-scale production of retinal pigment epithelial cells
|
WO2017021963A1
(en)
|
2015-08-03 |
2017-02-09 |
Biokine Therapeutics Ltd. |
Cxcr4 binding agents for treatment of diseases
|
EP3332009A1
(en)
|
2015-08-04 |
2018-06-13 |
Yeda Research and Development Co., Ltd. |
Methods of screening for riboswitches and attenuators
|
CN108138145A
(en)
|
2015-08-05 |
2018-06-08 |
细胞治疗神经科学有限公司 |
For treating the preparation of the photoreceptor of retinal disease
|
WO2017021973A1
(en)
|
2015-08-05 |
2017-02-09 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
EP3334449B1
(en)
|
2015-08-10 |
2021-09-29 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Methods and pharmaceutical compositions for improving wound healing using cd24
|
US20180237790A1
(en)
|
2015-08-13 |
2018-08-23 |
Forrest Innovation Ltd. |
Formulations and compositions for delivery of nucleic acids to plant cells
|
WO2017033188A1
(en)
|
2015-08-24 |
2017-03-02 |
Yeda Research And Development Co. Ltd. |
Algal oil and biofuel and methods of producing same
|
US10765706B2
(en)
|
2015-09-03 |
2020-09-08 |
University Of South Florida |
Method of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
|
WO2017042814A1
(en)
|
2015-09-10 |
2017-03-16 |
Yeda Research And Development Co. Ltd. |
Use of perforin positive immature dendritic cells in disease treatment
|
EP3365376A1
(en)
|
2015-10-25 |
2018-08-29 |
Yeda Research and Development Co., Ltd. |
Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of same
|
EP3368661A1
(en)
|
2015-10-26 |
2018-09-05 |
Cell Cure Neurosciences Ltd. |
Preparation of retinal pigment epithelium cells
|
CN109310648B
(en)
|
2015-10-27 |
2022-06-03 |
杰伊制药公司 |
Compositions comprising cannabidiol and a second therapeutic agent for treating cancer
|
IL242380A0
(en)
|
2015-10-29 |
2016-02-01 |
Yeda Res & Dev |
A method of inducing cardiomyocytes proliferation and treating heart diseases
|
WO2017077539A1
(en)
|
2015-11-03 |
2017-05-11 |
Ariel-University Research And Development Company Ltd. |
Compositions for regeneration and repair of neural tissue
|
EP3374524A4
(en)
|
2015-11-11 |
2019-06-26 |
Ramot at Tel-Aviv University Ltd. |
Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
|
WO2017094001A1
(en)
|
2015-11-30 |
2017-06-08 |
Kadimastem Ltd |
Methods for differentiating and purifying pancreatic endocrine cells
|
EP3176183A1
(en)
|
2015-12-02 |
2017-06-07 |
Yeda Research and Development Co. Ltd |
Compositions and methods for treating cancer not resistant to a tyrosine kinase inhibitor (tki)
|
EP4059507A1
(en)
|
2015-12-16 |
2022-09-21 |
Ramot at Tel-Aviv University Ltd. |
Particles comprising decellularized omentum
|
US10561706B2
(en)
|
2015-12-28 |
2020-02-18 |
B. G. Negev Technologies And Applications |
Isolated polypeptide and compositions comprising same
|
CN108697907A
(en)
|
2016-01-06 |
2018-10-23 |
耶达研究及发展有限公司 |
Composition for treating malignant disease, autoimmune disease and inflammatory disease and method
|
EP3403091B1
(en)
|
2016-01-11 |
2021-12-22 |
Technion Research & Development Foundation Limited |
Methods of determining prognosis of sepsis and treating same
|
BR112018014902A2
(en)
|
2016-01-21 |
2018-12-18 |
The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo |
solenaceous parthenocarpic plants, fruits and seeds of a plant, edible processed products, methods of production and reproduction of a plant,
|
IL243838A
(en)
|
2016-01-28 |
2017-07-31 |
Sp Nano Ltd |
Composition comprising sp1 and carbon based nanoparticles and uses thereof
|
IL243839B
(en)
|
2016-01-28 |
2018-01-31 |
Sp Nano Ltd |
Conductive yarn
|
WO2017130205A1
(en)
|
2016-01-31 |
2017-08-03 |
Hadasit Medical Research Services And Development Ltd. |
Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
|
CA3012302A1
(en)
|
2016-02-04 |
2017-08-10 |
Yeda Research And Development Co. Ltd. |
Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant p53
|
US20190142875A1
(en)
|
2016-02-14 |
2019-05-16 |
Yeda Research And Development Co. Ltd. |
Microbiome-based diagnosis, prediction and treatment of relapsing obesity
|
WO2017138008A2
(en)
|
2016-02-14 |
2017-08-17 |
Yeda Research And Development Co. Ltd. |
Methods of modulating protein exocytosis and uses of same in therapy
|
EP3416488A1
(en)
|
2016-02-16 |
2018-12-26 |
Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. |
Non-protein phenylalanine analogues for inhibiting cyanobacteria and plant growth
|
WO2017145162A1
(en)
|
2016-02-23 |
2017-08-31 |
Chaya Brodie |
Generation of cancer stem cells and use thereof
|
CA3015619A1
(en)
|
2016-03-01 |
2017-09-08 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Antibodies specific to human poliovirus receptor (pvr)
|
US20190085378A1
(en)
|
2016-03-03 |
2019-03-21 |
Memed Diagnostics Ltd. |
Analyzing rna for diagnosing infection type
|
US20190216891A1
(en)
|
2016-03-06 |
2019-07-18 |
Yeda Research And Development Co., Ltd. |
Method for modulating myelination
|
IL244649A0
(en)
|
2016-03-17 |
2016-06-30 |
Yeda Res & Dev |
Methods of isolating barrel-like proteases and identifying peptides processed thereby
|
US10421785B2
(en)
|
2016-04-11 |
2019-09-24 |
Bar-Ilan University |
Delta receptor agonist peptides and use thereof
|
DE202017007129U1
(en)
|
2016-04-27 |
2019-08-29 |
Gen-Probe Incorporated |
Lysis reagent for blood cells
|
WO2017203520A1
(en)
|
2016-05-22 |
2017-11-30 |
Yeda Research And Development Co. Ltd. |
Methods of using pulmonary cells for transplantation and induction of tolerance
|
IL245861A0
(en)
|
2016-05-25 |
2016-09-04 |
Yeda Res & Dev |
Use of agents for treating drug resistant tumors
|
US20190100732A1
(en)
|
2016-06-02 |
2019-04-04 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Assay for the removal of methyl-cytosine residues from dna
|
WO2017212476A1
(en)
|
2016-06-05 |
2017-12-14 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Novel molecules for the treatment of inflammation
|
US20190160152A1
(en)
|
2016-06-09 |
2019-05-30 |
Opko Biologics Ltd. |
Long-acting oxyntomodulin formulation and methods of producing and administering same
|
WO2017221225A1
(en)
|
2016-06-19 |
2017-12-28 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Screening for chemotherapy resistance in human haploid cells
|
CN109661463B
(en)
|
2016-06-27 |
2023-04-04 |
耶达研究及发展有限公司 |
Reverse suppressor cells generated from memory T cells
|
EP4184167A1
(en)
|
2016-07-10 |
2023-05-24 |
MeMed Diagnostics Ltd. |
Early diagnosis of infections
|
WO2018011795A1
(en)
|
2016-07-10 |
2018-01-18 |
Memed Diagnostics Ltd. |
Protein signatures for distinguishing between bacterial and viral infections
|
IL246722A0
(en)
|
2016-07-11 |
2016-09-29 |
Yeda Res & Dev |
Combination therapy to increase endogenous nitric oxide (no) synthesis
|
CA3030533A1
(en)
|
2016-07-11 |
2018-01-18 |
Oren HERSHKOVITZ |
Long-acting coagulation factor vii and methods of producing same
|
US20190224244A1
(en)
|
2016-07-11 |
2019-07-25 |
Bonus Therapeutics Ltd. |
Cell compositions for tissue regeneration
|
US20200080050A1
(en)
|
2016-07-11 |
2020-03-12 |
Yaakov Nahmias |
Systems and methods for growing cells in vitro
|
WO2018020489A1
(en)
|
2016-07-24 |
2018-02-01 |
Yeda Research And Development Co. Ltd. |
Methods and kits for analyzing dna binding moieties attached to dna
|
EP3497231B1
(en)
|
2016-08-08 |
2023-10-04 |
Technology Innovation Momentum Fund (Israel) Limited Partnership |
Bacterial systems for analyzing ubiquitylated polypeptides
|
US20190180846A1
(en)
|
2016-08-10 |
2019-06-13 |
Memed Diagnostics Ltd. |
System and method for analysis of biological data
|
CN109843305B
(en)
|
2016-08-14 |
2023-03-10 |
雷蒙特亚特特拉维夫大学有限公司 |
Mesenchymal cell-derived exosomes for treating neurological disorders
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
WO2018037416A1
(en)
|
2016-08-25 |
2018-03-01 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for treating autoimmune diseases
|
WO2018047154A1
(en)
|
2016-09-07 |
2018-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Anti-nkp46 antibodies and therapeutic use of same
|
US11485971B2
(en)
|
2016-09-14 |
2022-11-01 |
Yeda Research And Development Co. Ltd. |
CRISP-seq, an integrated method for massively parallel single cell RNA-seq and CRISPR pooled screens
|
WO2018060998A1
(en)
|
2016-09-29 |
2018-04-05 |
Memed Diagnostics Ltd. |
Methods of prognosis and treatment
|
IL248468A0
(en)
|
2016-10-13 |
2017-01-31 |
Technion Res & Dev Foundation |
Use of caspase-3 inhibitors and caspase-3 activators in the manufacture of medicament for treating cancer and wound healing
|
IL248385A0
(en)
|
2016-10-18 |
2017-02-01 |
Yeda Res & Dev |
Treatment of a circadian rhythm disorder
|
WO2018087759A1
(en)
|
2016-11-10 |
2018-05-17 |
Yeda Research And Development Co. Ltd. |
Phosphotriesterases for treating or preventing organophosphate exposure associated damage
|
EP3545095A1
(en)
|
2016-11-28 |
2019-10-02 |
Yeda Research and Development Co., Ltd. |
Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
|
EP3548015A1
(en)
|
2016-11-30 |
2019-10-09 |
Yeda Research and Development Co. Ltd. |
Methods of treating liver toxicity and disorders
|
JP7271180B2
(en)
|
2016-12-01 |
2023-05-11 |
ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド |
Combination therapy for nerve damage
|
IL268126B2
(en)
|
2017-01-18 |
2024-02-01 |
Yeda Res & Dev |
Genetically modified veto cells and use of same in immunotherapy
|
IL250479A0
(en)
|
2017-02-06 |
2017-03-30 |
Sorek Rotem |
Isolated cells genetically modified to express a disarm system having an anti-phage activity and methods of producing same
|
IL250916A0
(en)
|
2017-03-02 |
2017-06-29 |
Geiger Benjamin |
Methods of culturing t cells and uses of same
|
US20200150125A1
(en)
|
2017-03-12 |
2020-05-14 |
Yeda Research And Development Co., Ltd. |
Methods of diagnosing and prognosing cancer
|
WO2018167780A1
(en)
|
2017-03-12 |
2018-09-20 |
Yeda Research And Development Co. Ltd. |
Methods of prognosing and treating cancer
|
IL269363B2
(en)
|
2017-03-16 |
2024-02-01 |
Lineage Cell Therapeutics Inc |
Methods for measuring therapeutic effects of retinal disease therapies
|
DK3607050T3
(en)
|
2017-04-05 |
2023-11-13 |
Yeda Res & Dev |
EX VIVO CULTURE SYSTEM AND METHODS FOR THE USE OF THE SAME
|
IL252151A0
(en)
|
2017-05-07 |
2017-07-31 |
Fainzilber Michael |
Methods of treating psychiatric stress disorders
|
JP7445429B2
(en)
|
2017-05-10 |
2024-03-07 |
アリエル サイエンティフィック イノベーションズ リミテッド |
Antibody purification method
|
WO2018216006A1
(en)
|
2017-05-21 |
2018-11-29 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Combination of markers for diagnosing cancer
|
WO2018216011A1
(en)
|
2017-05-23 |
2018-11-29 |
Technion Research & Development Foundation Limited |
Agents which inhibit gads dimerization and methods of use thereof
|
GB201708662D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing shelf-life of banana
|
GB201708665D0
(en)
|
2017-05-31 |
2017-07-12 |
Tropic Biosciences Uk Ltd |
Compositions and methods for increasing extractability of solids from coffee beans
|
WO2018220582A1
(en)
|
2017-05-31 |
2018-12-06 |
Tropic Biosciences UK Limited |
Methods of selecting cells comprising genome editing events
|
WO2018229764A1
(en)
|
2017-06-13 |
2018-12-20 |
Yeda Research And Development Co. Ltd. |
Treatment of advanced or progressive multiple sclerosis
|
WO2019012542A1
(en)
|
2017-07-13 |
2019-01-17 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Detecting tissue-specific dna
|
EP3652343A1
(en)
|
2017-07-13 |
2020-05-20 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Dual-probe digital droplet pcr strategy for specific detection of tissue-specific circulating dna molecules
|
US20200340057A1
(en)
|
2017-07-13 |
2020-10-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Dna targets as tissue-specific methylation markers
|
IL253642A0
(en)
|
2017-07-24 |
2017-09-28 |
Seger Rony |
Combination therapy for the treatment of cancer
|
IL253984A0
(en)
|
2017-08-14 |
2017-09-28 |
Yeda Res & Dev |
Immunotherapy against transferrin receptor 1 (tfr1)-tropic arenaviruses
|
US11692166B2
(en)
|
2017-08-23 |
2023-07-04 |
Technion Research & Development Foundation Limited |
Compositions and methods for improving alcohol tolerance in yeast
|
EP3684929A1
(en)
|
2017-09-19 |
2020-07-29 |
Tropic Biosciences UK Limited |
Modifying the specificity of non-coding rna molecules for silencing gene expression in eukaryotic cells
|
AU2018364630A1
(en)
|
2017-11-09 |
2020-05-21 |
Pinteon Therapeutics Inc. |
Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with improved properties
|
EP3717032B1
(en)
|
2017-11-29 |
2023-02-15 |
Ramot at Tel-Aviv University Ltd. |
Methods of preventing or treating neurogenic shock
|
AR114936A1
(en)
|
2017-11-29 |
2020-11-11 |
Weedout Ltd |
COMPOSITIONS, KITS AND METHODS FOR CONTROLLING THE AMARANTHUS WEED
|
WO2019106680A1
(en)
|
2017-12-03 |
2019-06-06 |
Yeda Research And Development Co. Ltd. |
Treatment of an ischemic heart disease
|
EP3723785A1
(en)
|
2017-12-17 |
2020-10-21 |
Yeda Research and Development Co. Ltd |
Cop9 signalosome (csn) complex modulators and uses thereof
|
EP3731965A1
(en)
|
2017-12-28 |
2020-11-04 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Method to reproduce circadian rhythms on a microfluidic chip
|
IL257225A
(en)
|
2018-01-29 |
2018-04-09 |
Yeda Res & Dev |
Treatment of sarcoma
|
IL257269A
(en)
|
2018-01-31 |
2018-04-09 |
Olender Tsviya |
Endoplasmic reticulum targeting signal
|
WO2019155465A1
(en)
|
2018-02-08 |
2019-08-15 |
Yeda Research And Development Co. Ltd. |
Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
|
EP3749689A1
(en)
|
2018-02-08 |
2020-12-16 |
Yeda Research and Development Co. Ltd |
Inhibitors of the 20s proteasome
|
WO2019162945A1
(en)
|
2018-02-23 |
2019-08-29 |
Carmel Haifa University Economic Corporation Ltd. |
Methods for treating memory impairment and cognitive dysfunction
|
US20200408761A1
(en)
|
2018-02-28 |
2020-12-31 |
The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center |
Methods of diagnosing and treating bladder cancer
|
EP3765034A1
(en)
|
2018-03-12 |
2021-01-20 |
Yeda Research and Development Co. Ltd |
Treatment of a heart disease
|
JP2021519283A
(en)
|
2018-03-29 |
2021-08-10 |
テクニオン・リサーチ・アンド・ディベロップメント・ファウンデーション・リミテッド |
Vesicles containing PTEN inhibitors and their use
|
WO2019186569A1
(en)
|
2018-03-29 |
2019-10-03 |
Yeda Research And Development Co. Ltd. |
Use of electric field gradients to control gene expression
|
IL258467A
(en)
|
2018-03-29 |
2018-07-04 |
Ilana Kolodkin Gal |
Methods of disrupting a biofilm and/or preventing formation of same
|
GB201807192D0
(en)
|
2018-05-01 |
2018-06-13 |
Tropic Biosciences Uk Ltd |
Compositions and methods for reducing caffeine content in coffee beans
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neoantigens
|
WO2019220441A1
(en)
|
2018-05-15 |
2019-11-21 |
Hadasit Medical Research Services And Development Ltd. |
Compositions and methods for treating cancer resistant to an anti-cancer agent
|
EP3801614A1
(en)
|
2018-05-27 |
2021-04-14 |
BioLineRx Ltd. |
Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors
|
CA3102978A1
(en)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
CA3102975A1
(en)
|
2018-06-07 |
2019-12-12 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Methods of regenerating and transforming cannabis
|
US11873322B2
(en)
|
2018-06-25 |
2024-01-16 |
Yeda Research And Development Co. Ltd. |
Systems and methods for increasing efficiency of genome editing
|
AU2019297677A1
(en)
|
2018-07-04 |
2021-02-25 |
Ukko Inc. |
Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
|
EP3818529A2
(en)
|
2018-07-08 |
2021-05-12 |
Yeda Research and Development Co. Ltd |
Person-specific assessment of probiotics responsiveness
|
MX2021000264A
(en)
|
2018-07-11 |
2021-05-12 |
Immunity Pharma Ltd |
Peptide compounds and therapeutic uses of same.
|
JP2021529547A
(en)
|
2018-07-11 |
2021-11-04 |
カール メディカル リミテッド |
SIRPα-4-1BBL variant fusion protein and how to use it
|
JP2021532780A
(en)
|
2018-07-31 |
2021-12-02 |
コルプラント リミテッド |
Transgenic events in tobacco, their detection methods and their use
|
IL261156A
(en)
|
2018-08-14 |
2020-02-27 |
Fass Deborah |
Chimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
|
CN113227359A
(en)
|
2018-08-24 |
2021-08-06 |
耶达研究及发展有限公司 |
Methods of modulating polarization of M2 macrophages and uses thereof in therapy
|
EP3852759A2
(en)
|
2018-09-20 |
2021-07-28 |
Yeda Research and Development Co. Ltd |
Methods of treating amyotrophic lateral sclerosis
|
EP3856225A1
(en)
|
2018-09-25 |
2021-08-04 |
BioLineRx Ltd. |
Methods of selecting treatment for cxcr4-associated cancer
|
IL262658A
(en)
|
2018-10-28 |
2020-04-30 |
Memorial Sloan Kettering Cancer Center |
Prevention of age related clonal hematopoiesis and diseases associated therewith
|
IL263184A
(en)
|
2018-11-21 |
2020-05-31 |
Yarden Yosef |
Method of treating cancer and compositions for same
|
WO2020152686A1
(en)
|
2019-01-23 |
2020-07-30 |
Yeda Research And Development Co. Ltd. |
Culture media for pluripotent stem cells
|
IL264768A
(en)
|
2019-02-10 |
2020-08-31 |
Sagi Irit |
Anti-matrix metalloproteinase 7 (mmp-7) inhibitory antibody and uses thereof
|
IL264854A
(en)
|
2019-02-14 |
2020-08-31 |
Bahat Anat |
Spt5 inhibitors and methods of use thereof
|
WO2020170240A1
(en)
|
2019-02-21 |
2020-08-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method for reduction drug-induced nephrotoxicity
|
EP3927807A1
(en)
|
2019-02-21 |
2021-12-29 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Methods of generating organoids for high throughput screening of drugs
|
JP2022522848A
(en)
|
2019-03-05 |
2022-04-20 |
ザ ステイト オブ イスラエル ミニストリー オブ アグリカルチャー アンド ルーラル ディベロップメント アグリカルチュラル リサーチ オーガニゼイション (エー.アール.オー.) (ボルカニ センター) |
Genome-edited bird
|
GB201903521D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
No title
|
GB201903520D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Modifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
|
GB201903519D0
(en)
|
2019-03-14 |
2019-05-01 |
Tropic Biosciences Uk Ltd |
Introducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
|
IL265486A
(en)
|
2019-03-19 |
2020-09-30 |
Yeda Res & Dev |
Bistable type ii opsins and uses thereof
|
WO2020194317A1
(en)
|
2019-03-28 |
2020-10-01 |
Yeda Research And Development Co. Ltd. |
Method of treating lipid-related disorders
|
WO2020202142A2
(en)
|
2019-03-31 |
2020-10-08 |
Yeda Research And Development Co. Ltd. |
Anti-viral and anti-tumoral compounds
|
IL266433B
(en)
|
2019-05-02 |
2020-11-30 |
Sagi Irit |
Compositions comprising the propeptide of lysyl oxidase and uses thereof
|
WO2020230133A1
(en)
|
2019-05-13 |
2020-11-19 |
Yeda Research And Development Co. Ltd. |
Cell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
|
IL266728B
(en)
|
2019-05-19 |
2020-11-30 |
Yeda Res & Dev |
Identification of recurrent mutated neopeptides
|
US20220213445A1
(en)
|
2019-05-22 |
2022-07-07 |
Hadasit Medical Research Services And Development Ltd. |
Methods of culturing human pluripotent cells
|
US20220251179A1
(en)
|
2019-05-28 |
2022-08-11 |
Shanghaitech University |
Composition and methods to treat ectodermal dysplasia 2, clouston type
|
EP3983531A1
(en)
|
2019-06-12 |
2022-04-20 |
Hadasit Medical Research Services and Development Ltd. |
Methods of generating oligodendrocytes
|
US20220307008A1
(en)
|
2019-06-16 |
2022-09-29 |
Yeda Research And Development Co. Ltd. |
Method for stabilizing intracellular rna
|
WO2020261281A1
(en)
|
2019-06-27 |
2020-12-30 |
Ramot At Tel-Aviv University Ltd. |
Semaphorin 3a antibodies and uses thereof
|
CA3145972A1
(en)
|
2019-07-04 |
2021-01-07 |
Ukko Inc. |
De-epitoped alpha gliadin and use of same for the management of celiac disease and gluten sensitivity
|
EP3997114A1
(en)
|
2019-07-11 |
2022-05-18 |
KAHR Medical Ltd. |
Heterodimers and methods of use thereof
|
US20220281960A1
(en)
|
2019-07-16 |
2022-09-08 |
Ramot At Tel-Aviv University Ltd. |
Compositions and methods for the treatment of tuberculosis
|
IL268111A
(en)
|
2019-07-16 |
2021-01-31 |
Fainzilber Michael |
Methods of treating pain
|
EP4004548A1
(en)
|
2019-07-29 |
2022-06-01 |
Yeda Research and Development Co. Ltd |
Methods of treating and diagnosing lung cancer
|
WO2021019536A1
(en)
|
2019-07-30 |
2021-02-04 |
The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) |
Methods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
|
WO2021028909A1
(en)
|
2019-08-12 |
2021-02-18 |
Yeda Research And Development Co. Ltd. |
Dna repair blood test for predicting response of lung cancer patients to immunotherapy
|
WO2021033176A1
(en)
|
2019-08-22 |
2021-02-25 |
Ariel Scientific Innovations Ltd. |
Scaled-up methods for purifying antibodies
|
EP4021463A1
(en)
|
2019-08-27 |
2022-07-06 |
Yeda Research and Development Co. Ltd |
Treatment of bacterial vaginosis
|
WO2021048852A1
(en)
|
2019-09-11 |
2021-03-18 |
Yeda Research And Development Co. Ltd. |
Methods of treating breast cancer
|
IL269674B
(en)
|
2019-09-25 |
2020-08-31 |
Roy Bar Ziv |
Assembly of protein complexes on a chip
|
IL270306A
(en)
|
2019-10-30 |
2021-05-31 |
Yeda Res & Dev |
Prevention and treatment of pre-myeloid and myeloid malignancies
|
WO2021084526A1
(en)
|
2019-10-31 |
2021-05-06 |
Yeda Research And Development Co. Ltd. |
Engineered autotrophic bacteria for co2 conversion to organic materials
|
CA3160506A1
(en)
|
2019-11-11 |
2021-05-20 |
Ibi-Ag Innovative Bio Insecticides Ltd. |
Insect control nanobodies and uses thereof
|
JP2023510464A
(en)
|
2019-11-19 |
2023-03-14 |
プロタリクス リミテッド |
Removal of constructs from transformed cells
|
IL270800A
(en)
|
2019-11-20 |
2021-05-31 |
Yeda Res & Dev |
Method of treating alzheimer’s disease
|
IL271656A
(en)
|
2019-12-22 |
2021-06-30 |
Yeda Res & Dev |
Systems and methods for identifying cells that have undergone genome editing
|
WO2021130753A1
(en)
|
2019-12-22 |
2021-07-01 |
Yeda Research And Development Co. Ltd. |
Diagnosis of frontotemporal dementia
|
WO2021137231A1
(en)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
|
IL271778A
(en)
|
2019-12-31 |
2021-06-30 |
Ichilov Tech Ltd |
Methods of treating atopic dermatitis
|
WO2021137230A1
(en)
|
2019-12-31 |
2021-07-08 |
Kahr Medical Ltd. |
Methods of culturing t cells and uses of same
|
IL272074A
(en)
|
2020-01-15 |
2021-07-29 |
Immunity Pharma Ltd |
Peptide compounds and methods of treating diseases using same
|
IL272194A
(en)
|
2020-01-22 |
2021-07-29 |
Yeda Res & Dev |
Multispecific antibodies for use in treating diseases
|
WO2021152584A1
(en)
|
2020-01-28 |
2021-08-05 |
Ariel Scientific Innovations Ltd. |
Methods of analyzing cell membranes
|
WO2021152586A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Methods of analyzing microbiome, immunoglobulin profile and physiological state
|
WO2021152587A1
(en)
|
2020-01-30 |
2021-08-05 |
Yeda Research And Development Co. Ltd. |
Treating acute liver disease with tlr-mik inhibitors
|
IL272390A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Methods of treating cancer
|
IL272389A
(en)
|
2020-01-30 |
2021-08-31 |
Yeda Res & Dev |
Articles of manufacture comprising anti pd-l1 antibodies and their use in therapy
|
WO2021156878A2
(en)
|
2020-02-09 |
2021-08-12 |
Nlc Pharma Ltd |
Rapid detection test for sars-cov-2
|
IL272586A
(en)
|
2020-02-10 |
2021-08-31 |
Yeda Res & Dev |
Method for analyzing cell clusters
|
WO2021173674A1
(en)
|
2020-02-26 |
2021-09-02 |
A2 Biotherapeutics, Inc. |
Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
|
EP4121441A1
(en)
|
2020-03-16 |
2023-01-25 |
Yeda Research and Development Co. Ltd |
Peptide analogs and use of same in treating diseases, disorders or conditions associated with a mutant p53 protein
|
AU2021245409A1
(en)
|
2020-03-29 |
2022-11-24 |
Yeda Research And Development Co. Ltd. |
Variants of beta-glucocerebrosidase for use in treating Gaucher Disease
|
AU2021248783A1
(en)
|
2020-03-31 |
2022-12-01 |
Biomuse Ltd. |
Bacteria for the prevention and treatment of smoke-induced lung damage
|
WO2021205444A1
(en)
|
2020-04-06 |
2021-10-14 |
Yeda Research And Development Co. Ltd. |
Methods of diagnosing cancer and predicting responsiveness to therapy
|
WO2021205459A1
(en)
|
2020-04-07 |
2021-10-14 |
Ramot At Tel-Aviv University Ltd. |
Cannabidiol-containing compositions and uses thereof
|
CA3177360A1
(en)
|
2020-04-13 |
2021-10-21 |
Exoprother Medical Ltd. |
Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
|
US20210322483A1
(en)
|
2020-04-16 |
2021-10-21 |
Ichilov Tech Ltd. |
Cell-derived particles presenting heterologous cd24 and use thereof in therapy
|
WO2021229577A1
(en)
|
2020-05-12 |
2021-11-18 |
Collplant Ltd. |
Collagen as a delivery tool for metal-based anti-viral agents
|
IL274811B
(en)
|
2020-05-20 |
2021-05-31 |
Yeda Res & Dev |
Indexing spatial information for a single-cell downstream applications
|
US20230293530A1
(en)
|
2020-06-24 |
2023-09-21 |
Yeda Research And Development Co. Ltd. |
Agents for sensitizing solid tumors to treatment
|
IL276599A
(en)
|
2020-08-09 |
2022-03-01 |
Yeda Res & Dev |
Mage-a1 specific t cell receptor and uses thereof
|
IL276627A
(en)
|
2020-08-10 |
2022-03-01 |
Yeda Res & Dev |
Compositions for diagnosis and treatment of coronavirus infections
|
WO2022038536A1
(en)
|
2020-08-18 |
2022-02-24 |
International Rice Research Institute |
Methods of increasing outcrossing rates in gramineae
|
IL277488A
(en)
|
2020-09-21 |
2022-04-01 |
Yeda Res & Dev |
Method for modulating weight
|
EP4217370A2
(en)
|
2020-09-23 |
2023-08-02 |
Yeda Research and Development Co. Ltd |
Methods and compositions for treating coronaviral infections
|
IL277743A
(en)
|
2020-10-01 |
2022-04-01 |
Yeda Res & Dev |
Method of diagnosing breast cancer
|
KR20230113283A
(en)
|
2020-10-05 |
2023-07-28 |
프로탈릭스 리미티드 |
Dicer-Like Knockout Plant Cells
|
IL301970A
(en)
|
2020-10-07 |
2023-06-01 |
Protalix Ltd |
Long-acting dnase
|
EP4228637A1
(en)
|
2020-10-15 |
2023-08-23 |
Yeda Research and Development Co. Ltd |
Method of treating myeloid malignancies
|
IL278401A
(en)
|
2020-10-29 |
2022-05-01 |
Yeda Res & Dev |
Polynucleotides for rna editing and methods of using same
|
WO2022097157A2
(en)
|
2020-11-09 |
2022-05-12 |
1E Therapeutics, Ltd. |
Catalytic sequence based methods of treating or preventing bacterial infections
|
CA3200350A1
(en)
|
2020-11-26 |
2022-06-02 |
Yanay OFRAN |
Modified high molecular weight glutenin subunit and uses thereof
|
IL279559A
(en)
|
2020-12-17 |
2022-07-01 |
Yeda Res & Dev |
Controlling ubiquitination of mlkl for treatment of disease
|
EP4267742A2
(en)
|
2020-12-28 |
2023-11-01 |
1E Therapeutics, Ltd. |
P21 mrna targeting dnazymes
|
KR20230126725A
(en)
|
2020-12-28 |
2023-08-30 |
1이 테라퓨틱스 엘티디. |
P21 mRNA target site for silencing
|
EP4274886A2
(en)
|
2021-01-10 |
2023-11-15 |
Supermeat the Essence of Meat Ltd. |
Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
|
US20240083843A1
(en)
|
2021-01-14 |
2024-03-14 |
Yeda Research And Development Co. Ltd. |
Methods of producing vitamin d
|
IL280340B
(en)
|
2021-01-21 |
2022-04-01 |
Yeda Res & Dev |
Antibodies, peptides and combinations of same for the treatment or prevention of coronavirus infection
|
JP2024506954A
(en)
|
2021-02-18 |
2024-02-15 |
イェダ リサーチ アンド デベロップメント カンパニー リミテッド |
Genetically modified bacteria for vaccine production
|
CA3208982A1
(en)
|
2021-02-18 |
2022-08-25 |
Ravid STRAUSSMAN |
Method of generating vaccines
|
IL281561A
(en)
|
2021-03-16 |
2022-10-01 |
Yeda Res & Dev |
Methods and devices for ex-utero mouse embryonic development
|
JP2024514252A
(en)
|
2021-03-30 |
2024-03-29 |
バイオエムエックス・リミテッド |
PSEUDOMONAS bacteriophage and its use
|
IL282188A
(en)
|
2021-04-08 |
2022-11-01 |
Yeda Res & Dev |
A combined use of ketamine and retigabine (ezogabine) for the treatment of psychiatric disorders
|
EP4337764A1
(en)
|
2021-05-12 |
2024-03-20 |
Biomx Ltd. |
Staphylococcus bacteriophage and uses thereof
|
IL283563A
(en)
|
2021-05-30 |
2022-12-01 |
Yeda Res & Dev |
Anti-microbial peptide (amp) signatures for diagnostics, stratification, and treatment of microbiome-associated disease
|
CA3219233A1
(en)
|
2021-06-06 |
2022-12-15 |
Ravid STRAUSSMAN |
Combined treatment for cancer
|
IL309333A
(en)
|
2021-06-13 |
2024-02-01 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
Method for reprogramming human cells
|
NL2028466B1
(en)
|
2021-06-16 |
2022-12-21 |
Sakata Holland B V |
Methods of sorting matthiola seeds
|
WO2022264076A1
(en)
|
2021-06-16 |
2022-12-22 |
Seedx Technologies Inc. |
Methods of sorting matthiola seeds
|
AU2022303086A1
(en)
|
2021-07-02 |
2024-01-18 |
Tropic Biosciences UK Limited |
Delay or prevention of browning in banana fruit
|
IL310226A
(en)
|
2021-07-18 |
2024-03-01 |
Gamida Cell Ltd |
Therapeutic nk cell populations
|
WO2023002492A1
(en)
|
2021-07-22 |
2023-01-26 |
Yeda Research And Development Co. Ltd. |
Codon optimization of nucleic acids
|
WO2023012798A2
(en)
|
2021-08-02 |
2023-02-09 |
Yeda Research And Development Co. Ltd. |
Antibodies for the treatment of cancer
|
WO2023012584A2
(en)
|
2021-08-03 |
2023-02-09 |
Genicity Limited |
Engineered tcr complex and methods of using same
|
EP4130028A1
(en)
|
2021-08-03 |
2023-02-08 |
Rhazes Therapeutics Ltd |
Engineered tcr complex and methods of using same
|
CA3228570A1
(en)
|
2021-08-10 |
2023-02-16 |
Yona Geffen |
Engineered nk cells, methods of their production and uses thereof
|
GB202112866D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to fusarium wilt in a banana
|
GB202112865D0
(en)
|
2021-09-09 |
2021-10-27 |
Tropic Biosciences Uk Ltd |
Resistance to black sigatoka disease in banana
|
IL286430A
(en)
|
2021-09-14 |
2023-04-01 |
Yeda Res & Dev |
Multispecific antibodies for use in treating diseases
|
WO2023105526A1
(en)
|
2021-12-08 |
2023-06-15 |
Yeda Research And Development Co. Ltd. |
Multipotent lung progenitor cells for lung regeneration
|
WO2023209708A1
(en)
|
2022-04-25 |
2023-11-02 |
Yeda Research And Development Co. Ltd. |
Compositions for altering cyclic adp-ribose secondary messenger signalling
|